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Abstract
Latinos of low socioeconomic status are disproportionately affected by diabetes Type II
complicated by poor adherence to diabetes Type II medications and management
programs. Self-management of diabetes Type II is a tool used to teach health education to
patients with diabetes. The objective of this retrospective quantitative study was to
explore if there are predictors of nonadherence to diabetes Type II medications and
programs among Latinos with diabetes Type II. Data from 200 patient records from a
community clinic in Fresno County California were analyzed using both bivariate and
multivariate analysis. Selected sociodemographic independent variables were age,
gender, income, migrant worker status, family size, and having received health education.
The dependent variable was adherence to medication and management programs. Gender
and health education were the only strong predictors of nonadherence to diabetes Type II
medications and programs among the study sample in the bivariate analysis. The
combination of gender and health education was the only strong predictor to diabetes
Type II medications and programs in the multivariate analysis. Recommendations include
personalized health education that incorporates a protocol for teaching patients about diet,
consumption of alcoholic beverages, exercise, medication, and the effects these behaviors
have on diabetes prevention and management. The implications for positive change
include decreasing complications, improving quality of life, and improving patient
satisfaction. The implications also include decreasing health care cost for stakeholders,
including patients, and insurance payers.
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Chapter 1: Introduction to the Study
According to Fonseca, Kirkman, Darsow, and Ratner (2012), nearly 26 million
people in the United States have diabetes Type II. Fonseca et al. found that 25% of the
population ages 25 and older have diabetes or are prediabetic. Furthermore, Gerber
(2010) found that diabetes Type II medication nonadherence, which is the cause for many
diabetes Type II complications, is high among Latinos, including migrant workers. The
National Diabetes Education Program (2007) reported that a cardiovascular disease is a
problem for persons with diabetes Type II, leading to disability and early death. The
National Diabetes Education Program added that 65% of individuals with diabetes Type
II die from coronary artery disease and stroke.
Horton (2012) described persons with diabetes Type II as having complications
that socially impact society. This impact is multifactorial from diabetes Type II
complications, medication nonadherence, depression, no access to health care, increased
emergency room visits to hospitalizations from hyperglycemia, and macro vascular
atherosclerotic cardio vascular disease. However, the Latino patient who better adheres to
diabetes Type II medications may experience fewer complications. A Type II patient’s
quality of life may improve if he or she complies with medication requirements,
decreasing emergency room visits and hospitalizations. Latinos have a higher opportunity
for severe complications impacting their daily life, work, home, and social environment.
Thus this, study provides information regarding management of diabetes Type II for the
migrant worker who moves from one state to another in search of work. Teaching these

2
patients how to best manage their diabetes Type II with diet, exercise, regular
medications, and how to access resources is a predictor that needs to be explored.
Chapter 1 is divided into 11 sections. Each section provides pertinent information
regarding the different topics. The introduction and background contains literature related
to the impact of diabetes Type II. In the problem statement and purpose of the study, I
discuss the problem being addressed and the intent of the study. I explain the research
question and hypothesis as well as the null and the alternative hypothesis for each
variable and for the research question. The theoretical and conceptual framework for the
study provides information regarding the theories, and I explain how the theory relates to
the study. The nature of the study provides information regarding the reason for choosing
the method and study design. The definition includes the definitions of the independent
variables as well as the dependent variables. Assumptions are used to clarify
characteristics of the study that are considered part of the Latinos diabetes Type II beliefs
but cannot be described in a true statement. A summary and conclusion close the chapter
with themes and how the study fills the gap in the literature.
Background
Cusi and Ocampo (2011) reflected on the importance of health care providers
being aware of the need for individualized intervention plans for the Latino patient.
Awareness of patients’ needs, cultural beliefs, and socioeconomic and
socioenvironmental barriers is important in order to plan interventions appropriate for the
patient. According to Cusi and Ocampo, a gap exists between ethnic/minorities in the
United States, with obesity and being overweight affecting more Latinos than Whites.
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Latinos with diabetes Type II poorly manage their disease and have a higher incidence of
hyperglycemia, high blood pressure, and elevated hyperlipidemia (Cusi & Ocampo,
2011). Latinos are also at a disadvantage as compared to Whites with more
cardiovascular disease and socioeconomic barriers, such as language, cost, and access to
resources, including health care (Cusi & Ocampo, 2011). In 2009, Latinos had a higher
prevalence of diabetes Type II as opposed to White patients; the prevalence of diabetes
Type II for Latinos was 11.8% as opposed to 7.1% for Whites (Cusi & Ocampo, 2011).
The predictors of this study were used to determine if there was an association among
Latinos with diabetes Type II nonadherence and adherence to medications. Cusi and
Ocampo recommended further studies relating to barriers that impact the Latino
community with diabetes Type II to improve the social impact, cost, disability, and even
death from complications. Hence, improving positive outcomes ought to be the goal for
clinicians and physicians. Adherence to medication, diet, and exercise are the triad for
better diabetes Type II outcomes.
Chan (2010) stated that medication nonadherence to medication regimens is a
health problem impacting the individual, family, community, and resources. Chan
estimated that nonadherence is responsible for approximately $100 billion a year in
health care costs. Therefore, health education is important not only by the health
educators but by the health care providers as well to improve diabetes Type II adherences
to medications (Chan, 2010).
The Centers for Disease Control and Prevention (CDC, 2011) noted that, in the
United States, the direct expense for diabetes Type II in 2007 was $116 billion for
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medical expenses and $58 billion for disability, work loss, and premature death. The
CDC reported on complications such as heart disease as the cause of death in 68% of
diabetes-related deaths. Stroke was noted to be 16% of diabetes-related deaths. Other
complications self-reported by patients with diabetes Type II included 67% with
hypertension and diabetes. Moreover, blindness and eye problems were seen in
individuals between 20 and 74 years. The CDC reported that between 2005 and 2008, 4.2
million patients had some type of eye problem when they were examined and found that
655,000 diabetes Type II patients age 40 and older had a serious type of diabetic
retinopathy. The CDC reported that in 2008, there were 202,290 diabetics with end-stage
kidney disease living with regular dialysis or kidney transplant. Additionally, nervous
system diseases were found among 60% to 70% of patients with Type II diabetes,
including carpal tunnel syndrome, impaired sensation of lower extremities, and erectile
dysfunction.
Wroth and Pathman (2006) noted that, regardless of the number of studies done,
Latinos’ nonadherence to diabetes Type II medications continues to be a problem, and
little is known about why patients failed to follow clinicians’ recommendations. Smith
(2009) pointed out that Afro-Caribbean and Latino descent patients are at a higher risk of
diabetes Type II, and a gap still exists in relation to sociodemographics and diabetes Type
II affecting Latinos. In their database research relating to diabetes Type II and racial
ethnic minorities, Peek, Cargill, and Huang (2007) found that two-thirds of the studies
were controlled trials or randomized controlled trials. Therefore, Peek et al. proposed that
more studies are needed relating to patients with diabetes Type II of racial, ethnic
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minority groups. The specific characteristics ought to relate to the patient’s
sociodemographics, education, and other variables that relate to the patient’s
socioenvironment.
Thus, this study was needed to understand Latinos with diabetes Type II
nonadherences to medications, taking into consideration age, income, health education,
migrant worker status, family size, and gender. Understanding the predictors of
nonadherence affecting the Latino community is important to provide primary prevention
services to prevent new cases of diabetes Type II (Issel, 2009). Secondary prevention
includes providing screening to detect early cases of prediabetes or diabetes Type II and
teaching individuals to live with diabetes Type II without increasing morbidity and
mortality (Issel, 2009). Tertiary prevention decreases further complication of diabetes
Type II through early intervention of cardiac care and skin care, such as heart disease and
amputations (Issel, 2009). Knowledge of diabetes Type II obtained through scientific
research including health education for clinicians and communities can help improve
health outcomes.
Problem Statement
Diabetes Type II is a chronic disease that is prevalent in every community
worldwide. According to Fonseca et al. (2012), nearly 26 million people in the United
States have diabetes Type II. It was found that 25% of the population ages 25 and older
have diabetes or are prediabetic (Fonseca et al., 2012). In the United States, 7.9 million
people have prediabetes Type II, as opposed to 1 million people with diabetes Type I
(Fonseca et al., 2012). Dall et al. (2010) found that the national cost for health care in
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2007 was $218 billion. Furthermore, according to He, Black, Lopez-Payan, Omark, and
Schillinger (2009), it cost California $24.5 billion to treat diabetics with Type II
complications. According to Gerber et al. (2010), a lack of adherence to diabetes Type II
medications is high among Latino patients. There are many barriers that contribute to
poor adherence not only to medications but to diet and exercise as well. These barriers
relate to patients’ values and beliefs, socioeconomic status, a lack of support systems, a
lack of knowledge of diabetes Type II, and transportation (Jin, Sklar, Oh, & Chuen,
2008).
Fortmann, Gallo, and Philis-Tsimikas (2011) conducted a multimediator crosssectional design model to show the importance of social support and community support
resources. Fortmann et al. found that social support and community support resources had
an effect on medication adherence among ethnic minority groups, including Latinos with
diabetes Type II. The participants were mainly females with low socioeconomic status,
below the federal poverty line, and low acculturation. Fortmann et al. asserted that the
problems with Latinos adhering to medications diet and exercise still existed.
Peek et al. (2007) concluded that ethnic groups, including Latinos with diabetes
Type II, were at a higher risk of having complications related to chronic diseases. Ethnic
minority groups have higher disparities in relation to diabetes Type II management
outcomes and quality of life (CDC, 2011). Therefore, Healthy People 2020 encourage
working at improving the quality of care and decreasing health care disparities among
minority groups.
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This study was needed to understand Latinos with diabetes Type II nonadherences
to medications and their barriers relating to age, income, health education, migrant
worker status, family size, and gender in order to improve their quality of life and prevent
diabetes Type II complications. The World Health Organization (WHO, 2003)
encouraged open communication between patients and providers to prevent
misconceptions. Poor communication is one factor in increasing medication
nonadherence. The health care team and health care system are related factors that are
important when providing care to patients of other ethnicities such as African Americans,
Asians, American Indians, and Latinos. Misconceptions are responsible for a lack of
motivation from both the patient and provider.
Purpose of the Study
I used a retrospective quantitative method research design to develop an
understanding of sociodemographic independent variables that may predict an association
to medications adherence among Latinos with diabetes Type II. The independent
variables included age, gender, income, migrant status, family size, and health education.
The dependent variable was adherence to diabetes Type II medications. A logistic
regression method was identified as the appropriate analysis criteria variable with two
possible outcomes. The methodology involved a retrospective logistic regression, five
independent variables, and one dependent variable.
Research Question and Hypotheses
The primary research question has six independent variables and one dependent
variable. This leads to six null and alternative hypotheses for testing.
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RQ1: Are there predictors (age, gender, income, migrant worker status, and
family size or health education) of nonadherence to medications among Latinos
with diabetes Type II?
H01: There is not an association between age and nonadherence to medications
among Latinos with diabetes Type II.
Ha1: There is an association between age and nonadherence to medications among
Latinos with diabetes Type II.
H02: There is not an association between gender and nonadherence to medications
among Latinos with diabetes Type II.
Ha2: There is an association between gender and nonadherence to medications
among Latinos with diabetes Type II.
H03: There is not an association between income and nonadherence to
medications among Latinos with diabetes Type II.
Ha3: There is an association between income and nonadherence to medications
among Latinos with diabetes Type II.
H04: There is not an association between migrant workers and nonadherence to
medications among Latinos with diabetes Type II.
Ha4: There is an association between migrant workers and nonadherence to
medications among Latinos with diabetes Type II.
H05: There is not an association between family size and nonadherence to
medications among Latinos with diabetes Type II.
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Ha5: There is an association between family size and nonadherence to
medications among Latinos with diabetes Type II.
H06: There is not an association between health education and nonadherence to
medications among Latinos with diabetes Type II.
Ha6: There is an association between health education nonadherence to
medications among Latinos with diabetes Type II.
Multivariate Analysis
A multivariate analysis method was used to test the association between
medication nonadherence and adherence to determine if there were strong predictor
values of any combination of two variables to diabetes Type II among Latinos. The
independent variables were age, gender, income, health education, family size, and
migrant worker status as predicators to medication nonadherence to determine an
association among Latinos with diabetes Type II medication adherence.
RQ2: Is there a combination of predictors to nonadherence to medications among
Latinos with diabetes Type II?
H07: The combination of age and gender is not a strong predictor of nonadherence
to medications among Latinos with diabetes Type II.
Ha7: The combination of age and gender is a strong predictor of nonadherence to
medications among Latinos with diabetes Type II.
H08: The combination of migrant workers and income is not a strong predictor of
nonadherence to medications among Latinos with diabetes Type II.
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Ha8: The combination of migrant workers and income is a strong predictor of
nonadherence to medications among Latinos with diabetes Type II.
H09: The combination of age and health education is not a strong predictor of
nonadherence to medications among Latinos with diabetes Type II.
Ha9: The combination of age and health education is a strong predictor of
nonadherence to medications among Latinos with diabetes Type II.
H010: The combination of income and family size is not a strong predictor of
nonadherence to medications among Latinos with diabetes Type II.
Ha10: The combination of income and family size is a strong predictor of
nonadherence to medications among Latinos with diabetes Type II.
H011: The combination of gender and health education is not a strong predictor of
nonadherence to medications among Latinos with diabetes Type II.
Ha11: The combination of gender and health education is a strong predictor of
nonadherence to medications among Latinos with diabetes Type II.
Theoretical Framework
Two theories were used as the theoretical framework for the research study. The
first was the social cognitive theory developed by Bandura (1998). The second theory of
interest was the self-determinant theory (SDT; Skinner et al., 2003). Together these
theories focus on the responsibility of care for oneself as it relates to diabetes.
The Social Cognitive Theory
The theoretical framework for the study was the social cognitive theory that
includes the SDT (Bandura, 1998; Glanz, Rimer, & Lewis, 2002). Bandura (1998)
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described the social cognitive theory as a multifactorial structure that operates in
conjunction with goals, outcome opportunities, and assumed environmental social
behavior. The theory facilitates actions that motivate humans’ health opportunities.
Proponents of this theory emphasize three factors: environment, people, and how
behavior affects a person’s actions and habits. Some concepts under the social cognitive
theory include knowledge and skill, environmental perception, values placed on
beneficial outcomes, the importance of self-monitoring, goal setting, and self-reward.
This theory is a perception of patients’ abilities to enact behaviors, make lifestyle
changes, and follow through on action plans. Self-efficacy is related to the cognitive
social theory. This theory shifts the responsibility for care to the patient (Skinner,
Cradock, Arundel, & Graham, 2003). The theory provides a framework for accepting and
determining an association between the environment, social factors, and behavior.
Understanding these behaviors and the personal social factors influencing these
behaviors, whether environmental or culturally, can help in identifying social or
environmental interventions influencing health outcomes (Bandura, 1998; Glanz et al.,
2002).
Self-Determinant Theory
The focus of the SDT is on control and motivation. This theory is similar to the
social learning cognitive theory. However, the SDT requires more extrinsic actions by the
individual. The SDT was part of the workshops used in the health district of Portsmouth,
United Kingdom to assist individuals in understanding the Type II diabetes disease
processes. Motivation is a highly known precursor for controlling diabetes Type II and
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self-management (Skinner et al., 2003). In a study of 2,973 participants getting care from
clinics using the integrated model from 2003 to 2004, Williams et al. (2009) used SDT as
a way of orienting their participants to a better physical and psychological health.
Developing a program that includes the SDT will allow the participants to be selfefficient and self-motivated about adhering to the recommendation from their physician
and other clinicians. SDT provides tools that assist patients in changing negative
behaviors for positive lifestyle changes (Williams et al., 2009).
Foundation for the Study
Bandura (1998) theorized that lifestyle and behavioral changes by patients are not
made at the spur of the moment, but by consciously developing methods of improving
how they are going to behave and respond to the social environment. These methods are
psychologically interpreted and self-directed and cause behavioral and lifestyle changes.
The foundation for the theoretical framework used to guide the research was based on the
concept that people cannot motivate themselves when attempting to change developed
habits from a young age. Individuals with diabetes Type II can use the SDT (Skinner et
al., 2003) and the social cognitive theory (Bandura, 1998) to self- monitor and selfregulate their actions by learning the physical outcomes that motivate behavior. These
include sensory experiences and physical social behaviors. In meta-analyses, researchers
have verified the function of the SDT values, regardless of how diverse an individual
might be in relation to health. Teaching the SDT and the social cognitive theory prepares
the person to predict these base functions, including sociodemographics characteristics
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and social factors relevant to chronic disease (Holden, Moncher, Schinke, & Barker,
1990; Stajkovic & Luthans, 1998).
Conceptual Framework
Concepts in relation to diabetes Type II nonadherent behaviors and lifestyle
changes are provided frequently in health care outpatient clinics, hospitals, and
emergency rooms. There are many reasons for nonadherence and, even though education
on nonadherance has been given for decades, the problem has not been resolved. Martin,
Williams, Haskard, and DiMatteo (2005) discussed increased morbidity and mortality
with nonadherence to medications affecting the patient’s well-being and increasing the
health care economic burden relating to diabetes Type II complications. The concept of
adherence management for Latino patients ought to be simple by eliminating complex
recommendations, encouraging daily medication use, and incorporating lifestyle changes
to diet and other behaviors. Martin et al. agreed that at least 40% of patients
misunderstand instructions given for prescribed medication and forget or even disregard
advice given by their physician or health educators. Twelve percent of people in the
United States with diabetes Type II do not fill their prescription, 12% do not take their
medication, 29% stop taking their medication before they run out, and 22% miss dosages
in order to have their medication for a longer period of time (American Heart
Association, 2009; Martin et al., 2005). Schectman, Nadkarni, and Voss (2002) noted that
sociodemographics and low socioeconomic status also yielded poor diabetes Type II
nonadherence, including negative health outcomes.
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Peek et al. (2007) described diabetes Type II management classified by the target
population, clinicians, and health care systems, concluding that patients have the ability
to self-manage if properly educated, thereby improving their self-outcome. The limited
number of epidemiological interventions that have been properly analyzed has
contributed to the poor adherence among racial ethnic groups including Latinos (Elliot,
Shinogle, Pelle, Bhosle, & Hughes, 2008). The models that have been tested had no
target population or specific need in the health care system (Noble, Mathur, Dent, Meads,
& Greenhalgh, 2011). The epidemiological prevalence of diabetes Type II is one in 10
U.S. adults as reported in 2007 (Noble et al., 2011). The increase of diabetes Type II has
affected individuals with limited resources, finances, education, and sociodemographic
instability, adding to diabetes Type II complications, depression, and poor adherence to
medications.
The problems with medication nonadherence exist among several ethnic groups in
the United States. However, nonadherence is more evident among people of limited
resources, including Latinos. The conceptual framework was used to improve health care
outcomes, prevent complications, and relate to the awareness of individuals’ necessities.
These necessities include knowledge of the disease, sociodemographic surroundings, and
motivation to self-manage the disease. The WHO (2003) noted that health education is
not only for patients but clinicians as well to be able to deliver similar protocols where
both the clinician and the patient are ready for adherence supported by a health delivery
system.
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Nature of the Study
The intent of the study was to determine if there were predictors of nonadherence
to diabetes Type II medications using a quantitative retrospective method design. The
objective of this retrospective quantitative research study was to understand the
association between the independent variables age, gender, income, migrant status,
family size, and health education among Latinos with diabetes Type II.
The logistic regression analysis was used to predict continuous variables, discrete,
or a combination of continuous and discrete. Age was treated as a continuous variable,
divided into age groups: 18 to 30 years of age, 31 to 45 years of age, 46 to 60 years of
age, and 60 and over. Sex was classified as males versus females, health education as yes
versus no, and migrant worker status as yes versus no. These were treated as dichotomous
variables. Health education was determined by diabetes Type II health education classes
the participant attended. Income was categorical dummy coded by the following
classification 0= none, 1=$1 to $10, 000 per year, 2=$10,001 to $15,000 per year,
3=$15,001 to 20,000 per year, and 4=$20,001 or more. The dependent variable in this
analysis was adherence to medications; the two levels of variables were adherence versus
nonadherence. A 95% confidence interval was used to represent the correlation between
the independent variables and the dependent variable with a p value of less than 0.01,
calculated by applying the Bonferroni correct. Overall model significance or the Omnibus
test of model coefficients for the logistic regression was examined by the effect of the
predictor variables on adherence to medication, presented with an X² coefficient. The
Cox and Snell R² and Nagelkerke R² were used to examine the percentage of variance
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accounted for the predicted variables. Predicted probabilities of an event occurring was
determined by the expected (β; Tabachnick & Fidell, 2012).
Logistic regressions overcome many of the restrictive assumptions of linear
regressions. Linearity, normality, and equality of variance are not assumed, nor is a
normally distributed error term variance assumed. The major assumption of the logistic
regression is that the outcome variable must be discrete. The data should not contain
outliers, and there should be a linear relationship between the odds ratio and the predictor
variables (Tabachnick & Fidell, 2012). Linearity with an ordinal or interval predictor
variable and the odds ratio can be checked by creating a new variable that divides the
existing predictor variable into categories of equal intervals and running the same
regression on these newly categorized versions as categorical variables. Linearity is
demonstrated if the B coefficient increases or decreases the linear steps (Garson, 2009).
Finally, a large sample is recommended, fitting with the maximum likelihood method.
Using discrete variables requires that there are enough responses in each category.
The data were collected using secondary, archived electronic medical records
from a database at Clinica Sierra Vista in Fresno, California, a nonprofit primary care
community clinic. This retrospective study covered the period from 2010 to 2014. The
database at Clinica Sierra Vista was linked to i2i Media Tracks that serviced eight clinics
from rural, suburban, and urban impoverished areas of Fresno, California. The data were
entered into IBM SPSS Statistics Software (Version 21). Frequencies, mean, and
standard deviations were calculated for age, gender, income, health education, family
size, and migrant worker status by adherence or nonadherence to diabetes Type II
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medications. Depending on the predictors, an outcome action plan with recommendations
to patient management and adherence to diabetes Type II medications was prepared. The
results of the data were presented to both clinicians and staff for them to encourage
patients to enter medication assistant programs, health system resources, and free
medication pharmaceutical programs available to patients with limited income.
Definitions
Adherence: The extent that patients take their medications, exercise and follow a
strict diet as directed by a clinician or medical physician (Skinner et al., 2003). Diabetes
Type II medication nonadherence is related to age and gender. Fischer et al. (2010)
described age and gender as possible predictors. However, the literature was limited in
the number of patients who fail to fill their prescriptions as recommended by their
physician and recommendations to exercise and diet. Fischer et al. described males and
younger adults as having better adherence to medications as prescribed by physicians.
Latinos, both males and females, have a higher rate of nonadherence to medications with
a higher number of complications (Peek et al., 2007).
Diabetes Type II: An illness that interrupts the body glucose pathway. Every cell
in the body needs glucose in order to function to its optimal potential. The glucose gets
into the cell with the help of an insulin hormone. When insulin is depleted, or the body
stops releasing insulin, glucose increases in the blood stream (McCulloch, Nathan, &
Mulder, 2012).
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Nonadherence: This term relates to a prescription or recommendation from a
clinician not followed by a patient. Nonadherence to medication is multifactorial and
changes with each situation and patient (White, 2011).
Primary prevention: Actions, activities, or interventions done to prevent disease
or illness. An example is daily exercise, a diet lower in cholesterol, salt, and fat, and
maintaining appropriate calories as recommended by the CDC, health educator,
nutritionist, or physician (Issel, 2009).
Secondary prevention: Providing screening tools for prediabetes or for diabetes
type II to start early intervention (Issel, 2009).
Tertiary prevention: Interventions or actions to prevent further complication of
diabetes Type II. Tertiary prevention assists in preventing diabetes Type II complications
such as amputations or renal disease (Issel, 2009).
Assumptions
Perez-Escamilla, Garcia, and Song (2010) described acculturation as playing a
role in migrant workers’ abilities to access health care. Increased risk behaviors such as
drug abuse, unsafe sex practices, chronic as well as infectious diseases, and nonadherence
to medications are behaviors affecting the Latino migrant workers. Perez-Escamilla et al.
noted that migrant workers and Latinos born in the United States with family ties in
Mexico often received health care from Mexico, including purchasing medications from
Mexico through a relative or friend. The migrant worker population is usually not well
documented, and specifics of the numbers are difficult to assume. Moreover, the migrant
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worker population is unknown, moving from one state to another with their families,
looking for agricultural work.
There are many cultural beliefs within the Latino population that determines the
outcome of diabetes Type II, such as El Susto. El Susto is a form of fear caused by
someone or something in the environment precipitating the beginning of an illness such
as diabetes Type II (Swan, 2010). Fatalismo is another health belief that determines the
individual’s response to diabetes Type II. Fatalismo means that the person cannot change
the direction of the disease (Campos, 2007). Familismo is an important aspect of the
family. The need of the family and other families come first, similar to the compadre
belief. Rios (1998) described Espiritismo as the belief system made of both good and evil
spirits that can affect a human’s health and quality of life.
Many Latinos depend on curanderos, a folk healer who uses home remedies and
herbs. The Latino population believes that curanderos have mental powers and abilities to
cleanse the body from evil spirits, including skills to manage many acute diseases as well
as chronic illnesses. Patients keep this information to themselves in fear of being judged
by Western medicine clinicians. Sociodemographics are variables that determine the
course, interest, and self- management of diabetes Type II by patients. The beliefs above
increase the assumption that the health history is not always accurately reported or
completed.
The study depended on the assumption that the archive electronic medical records
in the database were accurate and entered using precise data information by the
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originators of the data. It was assumed that the information provided by the patients was
accurate, including risk factors to diabetes Type II.
Scope
The retrospective quantitative research method design was done using a
secondary archived medical record review. This quantitative retrospective research study
covered the period from 2010 to 2014. The target population was Latinos from Fresno,
California age 18 and over with diabetes Type II.
Delimitation
The data were collected using secondary electronic archived medical record
reviews. The participants were mainly Latinos with diabetes Type II, males and females,
age 18 and over. Clinica Sierra Vista serviced eight clinics from rural, suburban, and
urban impoverished areas of Fresno. Nonadherence to diabetes Type II medications
among Latinos is a problem, increasing the complication rate and cost to the nation. The
study was limited to the sociodemographic variables of age, gender, income, migrant
worker status, family size, and health education. However, there are many variables
related to diet, physical activity, depression, folk remedies, and acculturation that
required further studies addressing the needs of Latinos with diabetes Type II.
Limitations
A disadvantage of a retrospective cohort study relates to the limited information
with no avenue for follow-up, providing only prior outcomes. Another limitation of a
retrospective design study is that it cannot identify cause and effect. Retrospective
research studies are prone to selection bias, secondary to loss of records. Due to limited
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access to data, the target population was limited to Latinos with diabetes Type II located
in Fresno, California. Latinos are Mexican Americans, immigrants from Mexico, Central
America, South America, and any other Hispanic person including Portuguese. New
patients diagnosed with diabetes Type II in 2014 may have limited information on
medication nonadherence.
Data were collected up to 5 years back in order to have an increased sample size.
The possible responses to the predictors defined were limited for consistency. Hypothesis
testing and statistical testing were done to prevent systemic errors.
The data were dependent on patients who had identified themselves as being of
Latino race on their data sheets. Some patients, however, might have falsely identified
themselves as being Latino, while patients who are Latino might not have identified
themselves as being of Latino race.
Significance of the Study
Horton (2012) described diabetes Type II complications as having a high impact
on their quality of life. This quality of life is impacted by diabetes Type II complications,
medication nonadherence, depression, no access to care, and hospitalizations. Horton
recommended understanding patients’ characteristics, their view of health care, and their
understanding of the disease. The health care provider’s approach to patients will
determine an effective positive outcome; including the patient’s social environment and
cultural barriers (Horton, 2012). Nonadherence to medications impacts the patients’ well
being, including their quality of life. Understanding why Latinos, one of the largest
groups in the United States, lack adherence to medications is an important step in

22
improving health care outcomes for this population. Health care costs will be decreased
due to reduced complications, improved quality of life, and reducing morbidity and
mortality among Latinos with diabetes Type II.
Summary
Chapter 1 contained an introduction to diabetes Type II medication nonadherence
among Latinos in the United States, the implications of diabetes Type II nonadherence to
medications, and how it relates to the sociodemographics predictors among Latinos,
including migrant workers. In this chapter, I provided information relating to prediabetes
and diabetes Type II complications and costs to the state, nation, community, and
individuals. Diabetes affects young individuals’ health including obesity, hypertension,
hyperlipidemia, and depression. I discussed the associations between the variables and
the outcome of diabetes Type II. The emphasis was on the Latino community in Fresno,
CA. This target population is at a higher risk of developing diabetes Type II at a young
age. Chapter 2 is a detailed description of the theoretical framework and literature
reviewed. Chapter 3 provides the methodology for the study. In Chapter 4, I present the
results of the study. In Chapter 5, I describe recommendations for future study and study
implications.
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Chapter 2: Literature Review
Introduction
Diabetes Type II is a chronic disease prevalent in every community worldwide.
According to Fonseca et al. (2012), nearly 26 million people in the United States have
diabetes Type II. Twenty-five percent of the population ages 25 and older have diabetes
or are prediabetic (Fonseca et al., 2012). Gerber et al. (2010) found that nonadherence to
diabetes Type II medications, which is the cause for many diabetes Type II
complications, is high among Latino patients. The National Diabetes Education Program
(2007) reported that cardiovascular disease is a problem for persons with diabetes Type
II, leading to disability and early death. The National Diabetes Education Program added
that 65% of individuals with diabetes Type II die from coronary artery disease and stroke
(Fonseca et al., 2012).
There is a 60% nonadherence to medications among Latinos with diabetes Type II
(Parada, Horton, Cherrington, Ibarra, & Ayala, 2012). Thus improving adherence to
diabetes Type II medications is a goal for every health care provider. However,
nonadherence to medications, diet, and exercise is a problem that carries many
complications; it affects the individual’s self-concept and self-satisfaction (Delamater,
2006; Gerber et al. 2010). Salas, Hughes, Zuluaga, Vardeva, and Lebmeier (2009) argued
that nonadherence to medications affects the cost effectiveness of pharmaceuticals,
costing the U.S. economy close to $100 billion per year. Lau and Nau (2004) researched
oral antihyperglycemic medication nonadherence preceding hospitalization and found
that 28.9% of diabetes Type II participants were nonadherent to medications. Researchers
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have described the significance of research with strategies to help patients understand the
importance of taking their medications.
Chapter 2 is divided into six sections. Each section provides information
regarding different topics. These sections are as follows: The introduction contains a brief
overview and statistical figures related to other studies; the literature search strategy
includes terms and criteria; the theoretical foundation and the conceptual framework
include the theories used in different studies; an extensive review of the literature relates
key variables and concepts to sociodemographic predictors of medication nonadherence;
and the final section includes a summary and conclusion.
Literature Search Strategy
The literature review was conducted using peer-reviewed articles dating from
1992 to 2012 on diabetes Type II medication nonadherence, adherence, and the
theoretical framework. The resources used included EMBASE, Cochrane Library,
Walden University Library, PubMed, Medline, and the National Library of Medicine.
Key terms used included nonadherence, adherence, compliance, cost, resource
utilization, and medication expenses. Other key terms are diabetes Type II,
hyperglycemia, antidiabetic medications, insulin, oral anti diabetic agents, and diabetesrelated complications.
Criteria selection for the peer-reviewed studies depended on publication date,
giving priority to articles from 2005 to present. Studies that related to glycosylated
hemoglobin (hbA1C) as a proxy were used as an alternative to medication adherence.
hbA1C is a well-accepted measurement of diabetes Type II hyperglycemic controls.
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Studies were excluded if the article provided insufficient data or did not have adherence
information.
Nonadherence is defined by different methods. Delamater (2006) defined
nonadherence as not following recommendations from physicians, dietitians, or
counselors. These recommendations relate to medications, diet, or exercise. Leichter
(2005) described nonadherence, as opposed to noncompliance, determining that the two
terms are similar. Noncompliance denotes a negative opinion in relation to diabetes,
whereas nonadherence implies failure to follow prescriptions given to patients by
physicians or counselors without partiality. Parada et al. (2012) studied Spanish-Speaking
Mexican-origin adults living along the US-Mexican border and found that 65% were
classified as nonadherent to medications and did not follow diabetes Type II
recommendations relating to behavior and lifestyle changes.
Theoretical Foundation
The theoretical foundation includes the theories used in different studies and the
relation to the theoretical framework. There have been different theories applied in past
research studies regarding nonadherence as opposed to adherence to medications, diet,
and exercise. White (2010) compared two groups of patients in Denmark. One group was
continually evaluated by their physicians using diabetes Type II specific-goals,
information, patient education, patient feedback about the management of diabetes Type
II, and an assessment of the outcomes. The second group was set up using a conventional
approach with nonintervention physicians. The group with goal settings responded with
positive outcomes, decreased hbA1C, decreased blood glucose, lower blood pressure, and
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decreased cholesterol levels at the end of 6 years. The conventional therapy group of
diabetes Type II participants had negative outcomes with no changes in their lifestyle
behaviors (White, 2010). Another method of changing lifestyle behaviors in patients with
diabetes Type II was the use of systems interventions. This type of intervention attempts
to improve environmental factors that guide self-management by intervening with
economic determinants. The intervention is done through policies and protocols to
provide for test strips, lancets, and glucose meters. Other programs, such as
transportation, are also provided to improve the quality of care (White, 2010). In order to
improve patient adherence, patients and physicians must take an active role in health
education relating to medications, diet, and exercise. Adherence to diabetes Type II
medications requires theories and philosophies related to self-management and education
of individuals with diabetes Type II. Skinner et al. (2003) described the self-regulation
theory that focuses on individuals’ behaviors, emotions, and response to the disease. The
six core basic elements are
1.

Identify signs and symptoms of the disease.

2.

Describe the risk factors relating to diabetes Type II.

3.

Be aware of how long a person has diabetes Type II.

4.

Understand the consequences of diabetes Type II in the present and in the

future.
5.

Explain how to maintain diabetes Type II daily controlled.

6.

Know the complications of not treating diabetes Type II.
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Dual Process Theory
The dual process theory has been used in the education of diabetes Type II disease
processes. The health district of Portsmouth, United Kingdom conducted a series of selfmanagement workshops for patients newly diagnosed with diabetes Type II to improve
adherence to medications, diet, and exercise. The individuals were asked about their
understanding of diabetes Type II as well as the signs and symptoms. These individuals
were provided with information regarding diabetes Type II (Skinner et al., 2003). Skinner
et al. (2003) used the theory to improve diabetic education in assisting individuals with
diabetes Type II to follow medication, diet, and exercise recommendations. Through
active participation, the individuals with diabetes Type II were able to understand the
meaning of diabetes, the management of the disease, and the prevention of complications.
The individual was responsible for active participation in their lifestyle behavioral
changes and self-management. This included improving adherence to medication, diet,
and exercise (Skinner et al., 2003).
Self-Determinant Theory
The focus of the SDT is on control and motivation. This theory is similar to the
social learning cognitive theory. The exception is that it requires extrinsic actions by the
individual. SDT was part of the workshops used in the health district of Portsmouth,
United Kingdom to assist individuals in understanding the diabetes Type II disease
processes. Motivation is a precursor for controlling diabetes Type II and selfmanagement (Skinner et al., 2003). In a study of 2,973 participants getting care from
clinics using the integrated model from 2003 to 2004, Williams et al. (2009) used SDT as
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a way of orienting their participants to better their physical and psychological health.
Williams et al. concluded that developing a program that included the self-determinant
theory will allow the participants to be self-efficient and self-motivated about adhering to
the recommendation from their physician and other clinicians. The SDT provides tools
that assist patients in changing negative behaviors for positive lifestyle changes
(Williams et al., 2009).
Social Cognitive Theory
The social cognitive theory is the perception of patients’ ability to enact
behaviors, make life style changes, and follow through on action plans. SDT is related to
the cognitive social therapy. This theory shifts the responsibility for care to the patient
(Skinner et al., 2003) and was used as the theoretical framework of the research study; it
includes the self-efficacy learning theory (Bandura, 1998; Glanz et al., 2002). Bandura
(1998) described the theory as a perceived multifactorial structure that operates in
conjunction with goals, outcome opportunities, and assumed environmental social
behavior; facilitating actions that motivate humans in health opportunities. This theory
includes three factors: environmental, people, and how behavior affects a person’s
actions and habits. Some concepts under the social cognitive theory include knowledge
and skill, environmental perception, values on beneficial outcomes, the importance of
self-monitoring, goal setting, and self-reward. The social cognitive theory provides a
framework for accepting and determining an association between the environment, social
factors, and behavior. Understanding these behaviors and the personal social factors
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influencing these behaviors can help in identifying social or environmental interventions
influencing the outcome (Bandura, 1998; Glanz et al., 2002).
Bandura (1998) theorized that that lifestyle and behavioral changes are
consciously developed methods of improving how patients are going to behave and
respond to the social environment. These functions are psychologically interpreted and
self-directed to be able to cause behavioral and lifestyle changes. The foundation for the
theoretical framework that was used to guide the research was based on the concept that
people cannot motivate themselves when attempting to change learned habits from a
young age. Therefore, the SDT and social cognitive theory empower individuals with
diabetes Type II to self-monitor and self-regulate their actions by learning the physical
outcomes that motivated behavior. These physical behaviors include sensory experiences
and physical social pleasures. The risk factors that influence diabetes Type II are a part of
the cycle. In meta-analysis studies, researchers have verified the function of self-efficacy
values, regardless of how diverse an individual might be in relation to health. The SDT
and social cognitive theory prepare the person to predict these base functions including
sociodemographics characteristics and social factors relevant to chronic disease (Holden
et al.,1990; Stajkovic & Luthans, 1998).
Conceptual Framework
Concepts in relation to diabetes Type II nonadherent behaviors and lifestyle
changes are heard frequently in health care outpatient clinics, hospitals, and emergency
rooms. There are many reasons for nonadherence, and even though education programs
have been given for decades, the problem has not been resolved. Martin et al. (2005)
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discussed increased morbidity and mortality with nonadherence to medications affecting
the patient’s wellbeing and increasing the health care economic burden relating to
diabetes Type II complications. The concept of adherence management for Latino
patients ought to be simple, eliminating complex recommendations, encouraging daily
medication use, lifestyle changes to diet, and other behaviors such as exercise. Martin et
al. agreed that at least 40% of patients misunderstand instructions given for prescribed
medication and forget or disregard advice given by their physician or health educators.
Twelve percent of Americans with diabetes Type II do not fill their prescription, 12% do
not take their medication, and 29% stop taking their medication before they run out, and
22% take their medication to have medication for a longer period of time (American
Heart Association, 2009; Martin et al., 2005). Schectman et al. (2002) noted that
sociodemographics and low socioeconomic status also yielded poor diabetes Type II
nonadherence, including negative health outcome.
Theorist and Philosophers
Gorge (1994) stated that a vegan diet should not be promoted as a way of life
because the financial limits of such a diet make it possible only for those with financial
means; others could not consume it safely. However, Tonstad, Butler, Yan, and Fraser
(2009) found in a study of 22,434 men and 38,469 women that vegetarianism potentially
protects against obesity and diabetes Type II. Many vegan individuals see this diet as a
phenomenon that helps decrease not only obesity but elevated lipids as well decreasing
cardiac events, which prevents early onset of diabetes Type II (Tonstad et al., 2009).
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The philosophy of Kaira et al. (2010) was based on patient advocacy and placing
the individual at the center rather than diabetes Type II. The goal of Kaira et al. was to
educate and empower individuals with diabetes Type II to adhere to diet, medications,
physical activities, and other recommendations to better the quality of life and outcome.
Snyder (2012) claimed that diet and exercise are first and medications second. This
philosophy’s concept is on diet control and weight loss. Snyder determined that if an
individual with diabetes loses at least 7% of weight, this individual has a better chance of
controlled diabetes Type II. Skinner et al. (2003) also placed the responsibility on the
patient. The patient is responsible for making decisions that will assist in being in control
of his or her diabetes Type II physical and emotional health outcomes. Snyder’s
recommendations were not only for the patient but for the health care provider as well to
treat the patient with respect, empathy, and warmth and to make the educational
experience a success. The philosophy of treating others with respect is valuable,
especially when working with people from different educational, cultural, and ethnic
backgrounds.
Stajkovic and Luthans (1998) examined self-efficacy, work-related performance,
and a correlation between self-efficacy and performance. Stajkovic and Luthans, used the
social cognitive theory, both self-reactive and contextual characteristics that influence
how the person views or perceives behavior. They also examined the association between
individuals and the overall basis for their behaviors, determining that there is a
correlation between self-efficacy and work-related behaviors. These work-related
behaviors include social behaviors as well as work-related health determinants such as
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depression, anxiety, and a lack of motivation. The social behaviors are related to
overeating, substance abuse, and smoking.
Literature Review Related to Key Variables and Concepts
Physiological Theories
The endocrine cells of the pancreas are located in the islets of Langerhans, made
up of two types of cells, Alpha-cells and Beta-cells. These cells are found scattered all
around the islet of Langerhans. The Beta cells make up 60% of the endocrine body of the
pancreas, responsible for insulin and myelin. Insulin is released in response to glucose
levels (Spellman, 2010).
DeFronzo and Tripathy (2009) concluded that skeletal muscle is the major site of
glucose uptake in humans in the postprandial state. DeFronzo and Tripathy noted the
changes in leg muscle through the precise estimate of leg muscle glucose uptake with
positron emission tomography, a tool proven effective in providing new information
about reduced muscle insulin tissue resistance in diabetes Type II. Glucose is not used by
the muscle cells with diabetes Type II. However, glucose is released into the blood
stream causing a hyperglycemic state. This change in insulin resistance increases
metabolic abnormalities, (DeFromzo & Tripathy, 2009; Spellman, 2010).
In a person with diabetes Type II, it is important to understand the action of
carbohydrates and insulin. After eating a meal, carbohydrates are broken down into small
glucose molecules in the gut. These glucose molecules are absorbed into the blood stream
elevating the glucose levels. The elevated glucose stimulates release of insulin from the
beta cells in the pancreas. Insulin allows the entrance of glucose into most of the cells to

33
be used as energy by binding to certain cellular receptors (Leahy & Pratley, 2011). When
glucose levels exceed the cell needs, the extra glucose is stored in the liver as glycogen.
The liver acts as a reservoir until glucose is needed by the cells. The liver produces
glucose from fatty acids and from proteins or amino acids through a process of
gluconeogenesis. Glycogenolysis and gluconeogenesis together help in increasing blood
glucose levels. Glycemia is controlled by a complex relation between the stomach,
pancreas, and the liver (Mealey, 2005).
Glycogenolysis
Glycogenolysis is how the body breaks down glycologen into glucose from the
liver and muscle tissue before it is used by the body. The breakdown can be of muscle
tissue called glucose 6-phosphate. The breakdown occurs in the cytoplasm of cells;
glycogen is the main product from carbohydrates. Glycogenolysis occurs during periods
of fasting or during exercise to provide 6-phosphatate for glycolysis as needed for
Adenosine Triphosphate (ATP) (Cellular Respiration, 2012).
Gluconeogenesis
Gluconeogenesis is the process of glucose from noncarbohydrate foods. The
major originators are pyruvate, lactate, glycerol, and glucogenic amino acids. A few main
organs require a constant supply of glucose to be used as energy. These organs are the
brain, renal medulla, erythrocytes, lens and cornea of the eye, exercising muscles, and
testes. About 90% of gluconeogenesis occurs on the liver and about 10% of
gluconeogenesis occurs in the kidney (Cellular Respiration, 2012)
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There are many other theories relating to diabetes Type II function and
dysfunction, as well as theories on how to approach this chronic disease. Leahy and
Pratley (2011) theorized that adipose tissue leads to insulin resistance and diabetes Type
II. This theory is known as the lipotoxocity ectopic theory. The lipotoxocity ectopic
theory alters the redistribution of fat in the skeletal muscle, liver, and beta cells by
sending messages to adipose tissue molecules increasing an adipose tissue inflammatory
response. This inflammatory response is known as the secreted factor theory that causes a
low grade pro-inflammatory response affecting the insulin production and beta cells
function leading to diabetes Type II (Leahy & Pratley, 2011). Leahy and Pratley pointed
to central obesity or the fat found around the waist. This fat is not considered to be
subcutaneous fat predisposing people to insulin resistance and diabetes Type II.
Lebovitz ‘s (1999) theory was that diabetes Type II depended on genetic, as well
as environmental factors, and that it resulted from evolution of a thrifty genotype that had
survived in the past but has grown in the present time. Lebovitz compared the theory and
determined that it represents an adult metabolic response to fetal malnutrition. Lebovitz’s
philosophy was that diabetes Type II is attributed to insulin deficiency. Lebovitz’s theory
has been controversial. However, Khoury, Bedrosian, Gwinn, Ioannidis, and Little (2010)
identified phenotype similarities among families with diabetes Type II.
Remington, Brownson, and Wegner (2010) noted that there are many factors that
contribute to diabetes Type II such as smoking, obesity, hypertension, and elevated lipids.
Other contributing factors consist of physical inactivity, poor diet, smoking, and alcohol
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consumption. Obesity increases the risk of insulin resistance, increasing a chance for
diabetes Type II (Remington et al. 2010).
Rubino’s (2008) theory is that the problem with diabetes relates to the duodenum
or the small bowel in the pathophysiology of the disease. Rubino discussed the
rearrangement of the gastrointestinal anatomy as a primary means of preventing or
stopping diabetes Type II in morbid obese individuals. Rubino theorized that diabetes
Type II is an intestinal disease, proposing Roux-en-y gastric bypass surgery, in
combination with bilious-pancreatic diversion (BPD).
Pathogenesis of Diabetes Type II
Diabetes Type II is not clearly understood. It is believed to be linked to obesity
and genetic predisposition to certain families within the same culture. Diabetes Type II is
also recognized in groups with low socioeconomic position (Ramlo-Halsted & Edelman,
2000). Diabetes Type II is higher in Latinos, African Americans, Pacific Islanders, and
American Indians. Ramlo-Halsted & Edelman determined that many risk factors
contribute to diabetes Type II insulin resistances such as obesity, aging, and a lack of
exercise. They also concluded that a lack of self- management comprehension and
decreased cognitive abilities contribute to risk factors that increase the complications of
diabetes Type II, including elevated glucose and free levels of fatty acids.
Diabetes Type II is considered to be a metabolic triad defect affected by insulin
resistance, B-cell dysfunction, and hepatic glucose dysfunction (Ramlo-Halsted &
Edelman, 2000). Insulin resistance is recognized by high levels of glucose in the blood
stream. Pancreatic B-cell dysfunction is caused by the release of increased levels of
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glucose stimulating insulin. Impaired hepatic dysfunction is caused by increased glucose
production. After eating, persons with diabetes Type II have a combination of increased
glucose postprandial, ineffective release of insulin, and suppression of glucose output
needed by target tissue cells, such as skeletal muscles (Ramlo-Halsted & Edelman, 2000).
Obesity, a lack of exercise, and risky behaviors such as smoking and alcohol
consumption contribute to increased glucose and decreased insulin from the pancreas Bcells. In time, insulin resistance becomes chronic where no insulin is released and
exogenous insulin is required (Ramlo-Halsted & Edelman, 2000). Many patients have no
concept of why they have diabetes Type II. Latinos believe that it is part of el susto, a
frightening experience that causes an acute stress situation affecting the body physically
and mentally.
Diagnosis of Diabetes Type II
The American Diabetes Association’s (2012) new recommendations differ from
the old recommendations. The old recommendations for diabetes Type II were based on
fasting plasma glucose (FPG) or a two hour value after taking 75 gram of oral glucose
tolerance test (OGTT). The new recommendations were standardized by the American
Diabetes Association, the International Diabetes Foundation (IDF), and the European
Association for the Study of Diabetes (EASA). The EASA made recommendations to use
the hbA1C test as a mean of diagnosing diabetes Type II, with a threshold of >6.5%.
Their recommendations were accepted by the American Diabetes Association in 2010
(American Diabetes Association, 2012).
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Epidemiology
Inzucchi et al. (2012) noted that diabetes Type II prevalence is increasing
worldwide, but at a higher number in underdeveloped countries and higher among
individuals with obesity, elevated hyperlipidemia, and hypertension. The trend is thought
to be related to lifestyle behaviors that are associated with the Western world, in
particular, diet and exercise. The economic burden is high and continues to climb
(Inzucchi, 2012). Chan (2010) reported that 10% of hospitalizations and 23% of nursing
home admissions per year are related to diabetes Type II non adherence, increasing the
health care cost to around $100 billion a year. Parada et al. (2012) documented an
increase in medication nonadherence of Latinos with diabetes Type II. The study was a
randomized controlled trial of 302 patients randomly sampled, and Parada et al. found
that 60% of patients were nonadherent to diabetes Type II medications. Latinos are more
likely to have a higher rate of nonadherence to diabetes Type II medications (Horton et
al., 2012). Nonadherence to medications, diet, and exercise remains the most important
reason for cardiovascular disorders, blindness, end-stage renal failure, amputations, and
hospitalizations (Martin et al., 2005).
Kockaya and Wertheimer (2011) revealed that diabetes Type II is linked to
depression, decreased cognitive abilities, cancer, neuropathies, and other disabling
conditions, including death. In a study done between 1998 and 2002, the CDC (2011)
found that where Latinos dwell is of importance on how diabetes impacts each person’s
life due to cultural influence. Wabe, Angamo, and Hussein (2011) indicated that the
worldwide adherence rate of diabetes Type II medications was approximately 36% to
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93%, depending on the demographics and socioeconomic status of the individuals. Wabe
et al. found that prescriptions in Ethiopia were given to 351 patients. Out of the 351
patients, 33 were prescribed insulin and 312 were prescribed oral hypoglycemic
medications. Out of the patients receiving oral medications, only 42.8% of patients
showed proper glycemic control. The reasons for nonadherence to medications as
reported to the investigators were limited finances and the fear of side effects from drugs.
A study done in the Netherlands showed that adherence to oral medications was
approximately 61% to 85% (Vervloet et al. 2011). In Nigeria, Adejoh (2012) showed
that 66% of patients were nonadherent to oral diabetes Type II medications. Chan (2010)
found that in the United States, adherence to medications was approximately 36% to 93%
depending on demographics and socioeconomic factors. Miccoli, Penno, and Del Prato
(2011) found in a retrospective cohort study of 2,741 participants, using the patient’s
medical and pharmacy claims from a managed care plan in Oregon, that nonadherence to
medications was 19% to 35%. In studies done of Latinos and Nigerians compared to the
Netherlands and Oregon researchers showed that patients of low socioeconomic factors
and demographics had a higher rate of diabetes Type II medication nonadherence.
Literature Review Related to the Study
The intent of the research study was to determine predictors of nonadherence to
diabetes Type II medications using a quantitative method design. The objective of this
retrospective quantitative research study was to develop an understanding of the
sociodemographic independent variables, age, gender, income, migrant worker status,
family size, and health education to predict adherence to medications among Latinos with
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diabetes Type II. A binary logistic regression with multiple variables was conducted. The
dependent variable was adherence to medications. The logistic regression permitted the
evaluation of the odds of membership in adherence versus nonadherence, overcoming
many of the restrictive assumptions of linear regression.
Methodology Relating to the Research Study
Gerber et al. (2010) discussed a mixed method study of nine patients with a mean
age of 58 years who had diabetes for 21 years or more. The clinical staff at the University
of Illinois, Chicago Medical Center assisted Latino patients with poorly controlled
diabetes Type II, determined by a hbA1C > 8.0%. A team research member assisted the
patients by completing their history, medication list, health literacy, medication benefits,
depression, social support and access to care, diabetes knowledge, language spoken in the
home, and numeracy. The team promoter of health worked with these patients at home, at
a clinic, and through telephone calls. Medication management was provided for 6
months. The health promoters worked to maintained open communication between the
pharmacist and the patient and in preventive complex patient barriers. The team worked
at improving medication adherence and to teach self-care adherence among Latinos with
Type II diabetes. The study required many hours of frequent communication with
patients, means to address barriers, and telephone call time to discuss any issues with
participants. The study was based on their hbA1C, health education, knowledge of
diabetes, and language spoken in the home. Their sociodemographics were used to aid in
improving the blood glucose levels for Latino patients with hbA1C > 8.0% residing in
low socioeconomic areas. The study provided information on the importance of
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collaboration with other health care providers such as the pharmacists, counselors, health
educators, and other members of health care teams.
The WHO (2003), in a review of literature using a cross-sectional design, found
that medication adherence is related to socioeconomic status depending on the diabetes
medication regimen. Fifty-nine patients, 25 years and older, were followed regarding
medication adherence. The WHO found that poor communication between patient and
provider increases the rate of nonadherence to medications. Therefore, health care teams
and health systems are important when providing care to patients of other ethnicities such
as African Americans, Asians, American Indian, and Latinos. Strategies and goals ought
to be set up first by the health care teams in order to improve communication to prevent
misconceptions (WHO, 2003). These misconceptions are responsible for a lack of
motivation from both the patient and the provider.
Studies have lacked adherence standards as part of the intervention or motivation
process. Miscommunication between the patient and provider created a deficit in the
patient’s health education with no intervention on how to reach the patient. The WHO
(2003) reviewed literature published from 1980-2001 and found that research on
adherence to diabetes Type II medications yields inconsistencies including variability.
More research is needed using instruments and different research designs. Variables
relating to general measurements such as gender, age, and complexity of treatment are
needed as opposed to specific variables (WHO, 2003). The sample size to meet the
research design is important for validity of the study to detect significant correlations
between the different variables.
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The variables used by the research studies included health status, behavioral
observations, permanent products, patient self-reports, diaries, and 24 hour recall
interviews. These indicators are important in the care of patients with diabetes Type II.
The problem with some of indicators is that they attract bias (WHO, 2003). Researchers
have shown factors that influence behaviors of diabetes Type II. The WHO (2003)
discussed the intrapersonal factors that affect behavior such as age, gender, self-esteem,
self-efficacy, stress, depression, and alcohol abuse. The interpersonal factors are
important to the well-being of patients. These factors are the quality of communication
between the patient, the provider and the patient’s social support system. The patient
must have some understanding of diabetes Type II, motivating them to adhere to the
provider’s recommendations and treatment regimen. The WHO discussed the
environmental factors, including the high risk situations and environmental systems.
Mann et al. (2009) researched diabetes Type II using a multivariate analysis
research design to predict association of medication nonadherence. Using a quantitative
method, Mann et al. used 151 participants from the inner city, measuring
sociodemographics factors, age, gender, employment, language, ethnicity, and income.
Mann et al. added to the variables hbA1C, diabetes history, and comorbidity as reported
by the patient. The study used the self-efficacy or regulation theory to base their research.
The study was made mainly of African American and Latinos residing in low
socioeconomic areas. Sixty-four percent of the participants were born in the United
States, and 31% were born in Puerto Rico. The participants reported high levels of
comorbidity. The comorbid condition included 80% who had hypertension and 61% of
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the participants who had hyperlipidemia. Other comorbid conditions affecting the
participants included 43% with depression and 23% with anxiety (Mann et al. 2009). The
univariate predictors of medication non adherence were around 28%. These individuals
had five beliefs about their diabetes Type II.
1.

You only have diabetes when your sugar is high.

2.

There are no consequences for poor nonadherence to diabetes Type II
medications.

3.

Diabetes has no symptoms.

4.

They have no control of their diabetes Type II.

5.

Diabetes interferes with their regular life.

The patients were divided into four medication beliefs: skeptical 6%, ambivalent 34%,
indifferent 5%, and accepting 55%. The skeptical participants were more likely to be
nonadherent. The ambivalent participants had a p=0.02, the participants who were
indifferent had a p= 0.03, and the participants who were accepting had a p= 0.001 (Mann
et al., 2009). Numerous studies have been done on nonadherence. However,
nonadherence problems continued to exist. The study emphasis was on the inner city
population. Using self-reporting for medication adherence and the sample size prevented
accurate associations between the variables. The health education from the participant’s
point of view was not given in a way they could understand or comprehend what was
being taught. The sociodemographic was inconsistent due to variation in study design and
target population (Mann et al., 2009).
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Mann et al. (2009) found that patients’ beliefs were inconsistent in relation to the
chronic disease model of diabetes Type II. Patients residing in the inner city had health
beliefs predictive of medication nonadherence. Strategies to target these beliefs when
working with inner city patients can help setup goals relating to patient health education.
Mann et al. encouraged further studies in relation to sociodemographics and other
variables relating to anxiety, depression, alcohol abuse, and smoking. Mann et al. pointed
out that regardless of the effectiveness of drug therapy, nonadherence continues to be a
problem for health care providers. The Morisky scale showed validity and reliability in
relation to medication adherence. The Morisky scale is made up of four questions relating
to medication. The questions are answered using yes or no. Mann et al. described one
example of a Morisky scale question: Do you ever forget to take your medicine? This
scale was used by Mann et al. to prove adherence was more accurate than self-reporting
by the patient.
White et al. (2011) conducted a quantitative cross-sectional study using bivariate
variables, the Spearman correlation coefficient, 15 questions in Spanish, and diabetes
Type II specific numeracy measured by a diabetes numeracy test (DNT). The objective of
the study was to see if there were any associations between the variables demographics,
health literacy, diabetes-specific numeracy, acculturation, self-efficacy, self-care
behaviors, and hbA1C levels. White et al. used the DNT to test for reliability and validity
of the measurement tool never used in research. The participants of the study were 144
Latinos with diabetes Type II. White et al. further detailed health literacy as opposed to
quantitative literacy. Health literacy is described as the ability to understand and process
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information provided regarding a person’s health to make appropriate decisions relating
to health care. In a prior study, 400 English- and Spanish-speaking patients with diabetes
Type II had lower health literacy associated with poor outcomes. The participants
consisted of 62% females, 81% uninsured patients, 78% of Mexican Nationality, and
96% with low level of acculturation. Quantitative literacy was described as being able to
understand and process numbers. Understanding numbers from the authors’ perspective
meant being able to calculate insulin accurately, count carbohydrates, calculate portion
sizes from food labels, and being able to read the glucose meter when testing blood sugar.
Patients who showed a low diabetes specific numeracy failed their physician
recommendations having poorer outcome and nonadherence. Lower diabetes selfefficacy in Latinos related to a lack of knowledge about diabetes Type II and limited
knowledge about numeracy. White et al. used the Spearman correlation coefficient (p)
values to test bivariate associations between DNT-15 Latino and sociodemographics,
gender, nationality, language, education level, health history regarding diabetes Type II,
including insulin. The DNT-15 Latino tool measurement is significantly associated with
the construct measurement of health literacy, general numeracy, and diabetes-specific
skills. Literacy is closely related to acculturation. Latinos were impacted by lack of
acculturation, limiting adoption to health care, knowledge, and beliefs from the main
culture (White et al. 2011).
The new measurement tool used by White et al. (2011) lacked validity and
reliability. The participants had no understanding of the DNT-15 tool, limiting the
association between self-efficacy, self-care behaviors, and insulin use, including
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glycemic control. White et al. called the limitations “floor effects” limiting the
researchers' ability to accurately determine the correlation between the independent
variables. White et al. determined that future research is needed in relation to
sociodemographics, self-efficacy and self-care behaviors using a measurement tool that
has validity and reliability. The sample size was limited to 144 participants, decreasing
the accuracy of the study (White et al. 2011).
White et al. (2011) discovered measurement information relating to glycemic
control. White et al. used chart information and glucose testing at patient clinics
providing information regarding the patient’s hbA1C. The patient’s cross-sectional study
design provided information regarding the association between variables, their
limitations, and weaknesses. The study emphasis was on health literacy and numeracy
presenting data that can assist providers in understanding the patient’s limitations when
conducting blood glucose tests. The information provided by the authors relating to
diabetes-specific numeracy and acculturation was important when teaching the patient
self-efficacy and self-care behaviors. Knowing that the patient is limited to diabetesspecific skills alerts the provider to encourage health education promoting a better
understanding of diabetes Type II disease processes and management (Mann et al., 2009).
Nozaki et al. (2009) conducted a cross-sectional prospective study with stepwise
multiple regression analysis using psychological tools to measure the association between
psychological factors and glycemic control of participants with diabetes Type II. The
study had 304 Japanese participants with diabetes Type II being managed at the
outpatient clinics. All participants were required to take the hbA1C test. The participants
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were also asked to complete the self-report psychological inventories: Diabetes
Treatment Satisfaction Questionnaire (DTSQ), Problem Areas in Diabetes Survey
(PAID), Well-Being Questionnaire 12 (W-BQ12), Self-Esteem Scale (SES), Social
Support Scale, and Self-Efficacy Scale, and hbA1C measure 1 year later. Data were
collected on demographics, age, and medical records. Nozaki et al. (2009) found that
there was an association between age; diet management; microvascular problems of
diabetes Type II; and the scores from the DTSQ, W-BQ12, PAID, SES, and the selfefficacy scale. According to the stepwise multiple regression analysis, there was an
association between the predictors at baseline hbA1C. The patients were followed for 1
year. Two hundred and ninety participants (95.4% of the 304) were assessed after 1 year
using the multiple regression analysis. Nozaki et al. (2009) determined that the DTSQ
and the PAID predicted a lower hbA1C and medication adherence.
The Nozaki et al. (2009) study had limitations relating to causal relationship
between variables tested and glycemic control: a causal model was not used. Self-care
and self-management were not correlated to medication adherence. Out of the
participants, 14 were not easily followed and four patients passed away. The Nozaki et al.
(2009) determined that the 14 patients were probably more dissatisfied with their
treatment plan. Nozaki et al. could not determine if there were any differences between
sociodemographics clinical or psychosocial variables after 1 year.
The strengths of the Nozaki et al. (2009) study were the correlation between
patient satisfaction and hbA1C control. Patient satisfaction denotes a better quality of life.
Patients who are satisfied follow the physician’s recommendations and treatment regimen
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plan. Nozaki et al. concluded that more regression analysis studies are needed in the
future using sociodemographics, age, gender, and quality of life satisfaction.
Boswell, Cook, Burch, Eaddy, and Cantrell (2010) completed a study using
original research articles relating to medication adherence, clinical recommendations,
economic, and use outcomes. The study included 13 chronic diseases. These diseases
were coronary artery disease (CAD), hyperlipidemia, heart failure (HF), hypertension,
postmyocardial infarction (post-MI), bipolar disorder, depression, schizophrenia, diabetes
Type II, migraine, seizures, asthma, and chronic obstructive pulmonary disease (COPD).
The variables of interest as described by the researchers were adherence, costs, outcomes,
hospitalization, economics, and Medicaid, including persistence and prescription drugs.
The data were collected from 1974-2010. Boswell et al. (2011) reviewed 105 articles
dealing with the chronic diseases being evaluated except articles relating to migraine.
Boswell et al. (2010) found that most of the articles showed a positive response to
medication adherence, 64.3% to 100% depending on the categorical variables and the
chronic disease. The highest level of positive outcomes related to post-MI,
CAD/hyperlipidemia and schizophrenia. Diabetes, hypertension, and asthma showed a
lower positive outcome but higher source of economic and use data.
A limitation to the Boswell et al. (2010) study was based on the lacked of related
studies to the identified chronic diseases and limited application of the plan research
strategies. These limitations prevented a proper evaluation of medication adherence to
diabetes, hypertension, asthma, and COPD. No literature was identified by researchers
relating to the adherence of medication for migraines. Another limitation related to a lack
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of individual variables dealing with adherence. The study emphasis was based on clinical
interventions, use, and economic outcomes. The numerical level system used to label the
literature reviewed became complex when there were limitations to the studies found on
the chronic disease, such as migraine medication adherence (Boswell et al., 2010).
Boswell et al. (2010) pointed out information in relation to the economic burden caused
by chronic diseases and the use of these services with poor adherence to medication or
physician recommendations. Medication adherence is a predictor of positive clinical
outcomes, lower health care cost, and less use of services relating to complications.
Boswell et al. recommended further studies related to independent variables that address
a specific chronic disease, such as diabetes Type II.
Mainous, Diaz, and Geeze (2008) analyzed data from 1999 – 2004 National
Health and Nutrition Examination Survey (NHANES). The NHANES uses a complex,
multistage, probability sampling design in selecting participants within the civilian
population. Mainous et al. (2008) noted that the survey overly sampled population
subgroups to increase the reliability and validity of determining health indicators
representative of the population. Mainous et al. (2008) looked at acculturation; healthy
lifestyle measures that included obesity, exercise, and diet; demographics characteristics;
and access to care. The demographic characteristics were age, sex, poverty-income ratio
(<1.0 versus >1.0), education, and access to care. Because of the complexity of the
survey, Mainous et al. (2008) used the SUDAAN Statistical software, RTI international,
Research Triangle Park, North Carolina to determine the weighting complex sampling
design. Bivariate tests were conducted to measure the association between acculturation
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by the SAS scores, country of birth, and lifestyle behaviors. Mainous et al. (2008)
showed that 36% - 69% of individuals nationally were more acculturated. Latinos with
diabetes Type II with less acculturation showed an annual income of less than $20,000
and were less likely to have completed high school. The differences between diet and
exercise were similar with the exception that less acculturated individuals exercised less
during leisure time. The bivariate analysis on dietary fiber and cholesterol were similar
between those who were acculturated and those who had less acculturation. The logistic
regression analysis showed that acculturated individuals, as opposed to those who were
less acculturated, were nonsmokers. Country of birth was not a strong indicator for a
healthier life style; however, Latinos who had acculturated into the main stream had a
better opportunity of health care access and better socioeconomic status (Mainous et al.,
2008).
The cross-sectional data set from Mainous et al. (2008) limited the results’ ability
to determine inferences regarding causal effects. Acculturation is significantly associated
with many indicators relating to a healthy lifestyle; however, acculturation is a complex
determinant due to the belief, values, and behaviors regarding health. The questions
regarding physician and patients diagnosed with diabetes Type II does not indicate the
recommendations given regarding the type of diagnosed diabetes. The information
provided by Mainous et al. (2008) was limited regarding the Latino immigrants’
background characteristics. The survey provided limited information in relation to the
Latinos’ adherence to medications (Mainous et al., 2008). Mainous et al. (2008) provided
information in relation to patient access to care, culture, and acculturation in association

50
to patients with diabetes Type II adapting to new cultural values. Mainous et al. also
pointed out that acculturation does not influence smoking or exercise. However, it
influences adherence to medication and treatment plans.
Rationale for Selection of the Variables and Concepts
The variables and concepts of this study included nonadherence to diabetes Type
II medications among Latinos in Fresno. The intent of the study was to determine
predictors of nonadherence to diabetes Type II. It was an attempt to understand the
following sociodemographic independent variables: age, gender, income, migrant status,
health education, family size. The dependent variable was adherence to medications. The
focus of the study was to understand people in their environment and how behaviors
affect a person’s actions and habits. The study included concepts such as knowledge,
skills, and the value placed on beneficial outcomes.
Explanation of Controversial Variables
Inconsistencies regarding the many variables researched were documented by the
reviewed researchers. The inconsistencies and limitations were related to sample size,
measurements tools used, and methodology design. The limitations in sociodemographic
were related to the predictors and the type of specific independent and dependent
variables measured. Another limitation was the minority groups that participated in the
different studies, including the demographics: inner city versus rural areas. Wroth and
Pathman (2006) noted that, regardless of the number of studies done, Latinos’
nonadherence to diabetes Type II medications is in a continuum and little is known about
why patients fail to follow clinicians’ recommendations. Smith (2009) pointed out that
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Afro-Caribbean and Latino descent patients are at a higher risk of diabetes Type II. The
gap still exists in relation to sociodemographics and diabetes Type II affecting Latinos.
The controversy found was in association to the philosophy of the researchers and
clinicians. In their database search relating to diabetes Type II and racial ethnic
minorities, Peek et al. (2007) found that two thirds of the studies were controlled trials or
randomized controlled trials. Peek et al. proposed that more studies are needed relating to
patients with diabetes Type II of racial, ethnic minority groups. The characteristics ought
to relate to the patient’s characteristics, sociodemographics, education, and other
variables that relate to the patient’s socioenvironment.
Synthesize Studies Related to the Research Question
The research question for the study related to sociodemographic predictors of
medication nonadherence among Latinos with diabetes Type II. The review of the
literature included only a few similar studies. However, these studies either had a
different methodology, few variables, or a limited number of participants. The study
related to Latinos with diabetes Type II in the Fresno. In a cross-sectional design study,
the WHO (2003) found that medication adherence is related to socioeconomic status and
poor communication between patients and providers. Mann et al. (2009) researched
diabetes Type II using a multivariate analysis research design. Mann et al. predicted
associations of medication nonadherence using a quantitative method of 131 participants.
The variables included sociodemographics from the inner city, age, gender, employment,
language, ethnicity, income, hbA1C, diabetes history, and comorbidity as reported by
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patients. This study is closely related to the present study except with a few different
variables and target population.
Recommendations for Other Studies
Fortmann, Gallo, and Phillis-Tsimikas (2012) and Peek et al. (2007) claimed that
Latinos are disproportionately affected by diabetes Type II, have a higher prevalence of
diabetes Type II, have higher hbA1C, and have an increased number of complications.
Fortmann et al. discussed the importance of communication between patients and
providers. It is equally important to provide avenues for social and environmental
support, including resources required to manage this chronic health condition. Resources
to manage diabetes Type II can be used to ensure medication adherence and prevent
depression and anxiety. Rustveld et al. (2009) found that self-esteem and a sense of
powerlessness can affect Latino American men with diabetes Type II. The data are
important when referring Latino male patients to health education and other types of
counseling.
Mann et al. (2009) described predictors to diabetes Type II medications. Mann et
al. added that the studies have been inconsistent in relation to target population, age, sex,
ethnicity, income, education, and comorbidity. Mann et al. found that beliefs about
causes and cures for diabetes Type II contribute significantly to the predictors of poor
medication adherence. Mann et. also reported the importance of cultural sensitivity when
tailoring educational classes to patients with diabetes Type II.
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Social Impact Relating to Medication Nonadherence
Horton (2012) described diabetes Type II complications as having a high impact
on a patient’s quality of life. This quality of life is impacted by diabetes Type II
complications, medication nonadherence, depression, limited access to care, and
hospitalizations. Horton recommended understanding patients’ characteristics, their view
of health care, and their understanding of the disease. The health care providers’
approach to patients will determine an effective positive outcome, including the patients’
social environment and cultural barriers (Horton, 2012).
Cusi and Ocampo (2011) reflected on the importance of health care providers
being aware of the need to tailor interventions for the Hispanic/Latino patient. According
to Cusi and Ocampo, a gap exists between ethnic minorities in the United States. The
Latino individual’s genetics is believed to influence diabetes Type II. Cusi and Ocampo
found that, in 2009, Latinos had a higher prevalence of diabetes Type II as opposed to
Caucasian patients. The prevalence of diabetes Type II for Latinos was 11.8% as opposed
to 7.1% for Caucasian individuals. Awareness of patients’ needs, cultural beliefs,
socioeconomic, and socioenvironmental barriers are important in order to plan
interventions appropriate for them. Cusi and Ocampo recommended further studies
relating to variables affecting Latino individuals. Improving positive outcomes ought to
be the goal for clinicians and physicians. Therefore, adherence to medication, diet, and
exercise is the triad for better diabetes Type II outcomes.
Chan (2010) described medications nonadherence as a health care problem,
impacting cost for the individual, family, and community. Chan (2010) estimated that
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nonadherence is responsible for approximately $100 billion a year in health care costs.
Health education is important not only for the health educators but for the health care
providers as well to improve diabetes Type II adherences to medications.
The CDC (2011) noted that the cost for diabetes care in the United States in 2007
was $116 billion for medical expenses and an indirect cost of $58 billion for disability,
work loss, and premature death. The CDC reported on complications such as heart
disease as the cause of death in 68% of diabetes-related death. Strokes were noted to be
16% of diabetes-related deaths. Other complications self-reported by patients with
diabetes Type II included hypertension and diabetes. Blindness and eye problems were
seen in individuals 20 to 74 years old in 2005 to 2008 during an examination of 4.2
million (CDC, 2011). People with diabetes aged 40 or older had diabetes retinopathy, of
these 655,000 had serious type of diabetic retinopathy. Kidney disease was reported on
48,374 people with diabetes (CDC, 2011).
The CDC (2011) reported that, in 2008, 2,002,290 people with diabetes and endstage kidney disease were living with regular dialysis or kidney transplants. Nervous
system diseases were noted in 60% to 70% of individuals. These individuals had mild to
severe nervous system diseases including carpal tunnel syndrome, impaired sensation, or
pain in their feet. Erectile dysfunction and other nerve problems were noted as well. The
CDC reported that, in 2006, 65,700 nontraumatic lower limb amputations were
performed.
Another problem with diabetes Type II is dental disease. Sanders-Polin (2012)
described periodontal gum disease as a problem with diabetics. Nonadherence to diabetes
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Type II medications increases the problem of periodontal gum disease due to poor
glycemic control and vascular disease that affects nutrition responsible for the destructive
inflammation of the gums. Poorly controlled diabetes Type II is the reason for the
development of periodontal gum disease. Fried (2012) described the risk factors of
periodontal disease that applies to many disorders including diabetes Type II. Individuals
with diabetes Type II have a higher risk of developing gingivitis and periodontal disease.
Periodontal disease impacts society, and patients. The literature was not specific to the
cost to treat and manage diabetics with periodontal disease. However, Persson (2011)
noted that periodontal disease is the sixth known complication for patients with diabetes
Type II. The treatment of periodontal disease is associated with positive outcomes.
Persson found that a person with diabetes Type II who is treated for periodontitis and has
a hbA1C > 9.0% has an opportunity to decrease their hbA1C to 0.6% with no change in
medication adherence, and patients with medication adherence have an opportunity to
decrease their hbA1C to 1.4%. There is sufficient evidence that supports the impact of
periodontal disease on systematic inflammation indicators (Persson, 2011).
Literature Reviewed on Social Change
There is a consensus among the investigators on medication adherence to prevent
diabetes Type II complications. Nonadherence to medications is multifactorial in relation
to race/ethnicity in minority groups. Latinos have many problems to overcome such as
limited resources, limited access to care, and position value, including how the person
views health. The benefits to medication adherence include glycemic control, less
complications, better quality of life, increased productivity, decreased premature deaths,
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and decreased disabilities related to diabetes Type II complications. The financial burden
to health care will be decreased and patients with diabetes Type II will have an
opportunity for patient satisfaction, decreasing depression, anxiety, and improved selfesteem. The study will impact social change by improving patients’ diabetes Type II
medication adherences and providing information to other health care providers about the
importance of ensuring that Latino patients understand the recommendations. I aimed to
improve policies at the state and community level relating to Latino patients barriers to
medication adherence, including diet and exercise, by looking for associations among
predictors specific to Latinos with diabetes Type II and nonadherences to medications.
Swan (2010) explained that helping patients understand their barriers to diabetes
management is important in preventing said barriers. Understanding why patients are not
able to self-manage their diabetes is important for the patient, the family, and the health
care provider. The independent predictors of nonadherence in this study were age,
gender, income, migrant status, family size, and health education for patients with
diabetes Type II. These variables were analyzed to help providers of care in
understanding the factors associated with adherence. The social impact in decreasing
cost, complications, improving quality of life, and patient satisfaction for both males and
females is important to stockholders who finance health care for the uninsured, insurance
payers, and state, including patients and families. The findings of this study could well
assist in changing or improving national policies in relation to self-management of
Latinos with diabetes Type II.
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Summary and Conclusions
This chapter included a description of diabetes Type II medication adherences
versus nonadherence and research studies conducted to improve the management of
diabetes Type II worldwide. The literature reviewed was a summary of the
methodologies and designs used in the research studies, including the intervention
conducted by different researchers to address the problem of nonadherences to
medications. The review also included several theories relating to causes of diabetes
Type II. The reviewed researchers suggested that social and environmental behaviors are
contributing factors to diabetes Type II nonadherences. I also reviewed prior
interventions to improve medication adherence through active patient participation and
health education, diet, and exercise
Chapter 3 will include detailed description of the methodology and research
design, sample size requirements, participant recruitment, data analysis, and ethical
considerations.
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Chapter 3: Research Method
Introduction
A quantitative retrospective research study was conducted to understand the
association between medication nonadherence among Latinos with diabetes Type II and
the independent variables that included age, gender, income, migrant worker status,
family size, and health education. These sociodemographic variables were used to predict
an association to diabetes Type II medication adherence among Latinos. The dependent
variable was adherence to diabetes Type II medications. A logistic regression analysis
was used to quantify the association between variables.
This chapter is divided into four sections. The introduction contains the
description and purpose of the study. The research design and rationale connect the
research questions with the research design. I define the research study, detailing the
population, the sampling size, and how the information was collected when using
archival data. It also contains the data analysis plan and how the data were interpreted.
The methodology section includes a description of the power size, using the alpha level
and power level of choice. The sections on threats to validity contain internal threats to
validity, history, and statistical regression.
Research Design and Approach
This quantitative retrospective method design study was used to determine if there
is an association between geographic characteristics of Latinos and the adherence to
diabetes Type II medications. These characteristics included age, gender, income,
migrant worker status, family size, and health education. The retrospective design was
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used because the data were entered into database files at Clinica Sierra Vista, Fresno,
California. Therefore, because the files contained existing data, the analysis was
considered secondary. The archived database files at Clinica Sierra Vista are linked to i2i
Media Tracks that services eight clinics from rural, suburban, and urban impoverished
areas of the city. The data were pulled from January 2006 to December 2011 from the
eight community health care center clinics. A series of bivariate analyses were conducted
for each of the independent variables, determining an association between the
independent variables and the dependent variable. A multivariate analysis was conducted
to determine if combinations of significant variable together formed a strong predictor
than the variable alone.
Methodology
Target Population
The target population was limited to Latinos from eight clinics across Fresno,
California with diabetes Type II. The general characteristics of the target population
included individuals living in impoverished areas of the city, with limited resources,
limited education, and income. The target population was comprised of a minimum of
111 Latino patients as calculated using G*Power in the sample size and power
calculation, see Selection of Participants below. The sample size was increased to 200 for
oversampling. The ages of the participants were 18 years of age or older, males and
females, who were working mainly as field workers. The i2i Media-Tracks database
contains over 14,000 entries with information regarding medications, laboratory results,
examinations, social and medical history, including random blood sugars or fasting blood
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sugar performed during the medical visit. The 200 patients were selected from the
database using a random number generator with a minimum of one and a maximum of
14,000.
Selection of Participants
The data were collected using secondary electronic medical record review. The
participants were Latinos with diabetes Type II. The inclusion and exclusion criteria for
qualifying patients from which data were gathered was males and females, 18 years of
age or older, with diabetes Type II, patients of Clinica Sierra Vista, Community Health
care Clinics, English- or Spanish-speaking. Patients were excluded if they had diabetes
Type I, gestational diabetes, or diabetes insipidus. The retrospective quantitative research
study data will be pulled from January 2006 to December 2011 for patients with at least 1
year of diagnosis and treatment.
Sample Size and Power Calculation
The research study involved the use of one logistic regression and six independent
variables. An effect size of 0.3 (medium) is generally an accepted range with a power of
0.95 and an alpha of 0.01 after applying the Bonferroni adjustment (Franz, Edgar, AlbertGeorg, Axel, & Buchner, 2009). Given those values, the desired sample size to achieve
empirical validity for the logistic regression with five predictors was a minimum of 111
patients as calculated using the G*Power 3.1.7 calculator. A total of 200 patients were
used as an oversampled size. LeBlanc and Fitzgerald (2009) described power as the
probability that the results of the study will provide statistical analysis actions to evaluate
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the hypotheses. Sample size is calculated using power to determine if the results are
statistically significant (Franz et al., 2009).
Characteristics of Selected Data
The database files at Clinica Sierra Vista are linked to i2i Media Tracks that
services eight clinics from rural, suburban, and urban impoverished areas of the city. The
data were entered into IBM SPSS Statistics Software (Version 21). Descriptive statistics
were conducted to describe the sample demographics, the research independent variables,
and the dependent outcome variable nonadherence to medication among Latinos with
diabetes Type II. Latinos were identified by race as specified in the demographics.
Nonadherence was defined as a failure to comply with medication as prescribed, which
included failure to take and/or refill their medication within at least a 6 month time frame.
The data were collected from the electronic Medication record database files linked to the
i2i Media Track or NextGen database. Frequency and percentages were calculated for
gender, income, health education, family size, and migrant worker status by
nonadherence to medications. Mean and standard deviations were calculated for age by
nonadherence to medications. Depending on the predictors, an outcome action plan with
recommendations to patient management and adherence to diabetes Type II medications
was prepared. Results of the data analysis will be presented to both clinicians and staff in
order for them to encourage patients to enter medication assistant programs, including
free medication pharmaceutical programs available to patients with limited income.
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Data Analysis
The intent of the study was to determine if there are predictors of nonadherence to
diabetes Type II medications using a quantitative method design. The objective of this
research study was to understand the association between sociodemographic independent
variables: age, gender, income, migrant worker status, family size, and health education.
The dependent variable was adherence to medications among Latinos with diabetes Type
II. A bivariate analysis for each independent variable was tested to see if there was an
association between the independent variable and the dependent variable. The
multivariate analysis method was used to identify strong predictor values of any
combination of two independent variables in relation to diabetes Type II among Latinos.
A logistic regression was conducted and is appropriate when the criteria variable
is dichotomous with two possible outcomes. One variable can estimate the possibility of
an event’s occurrence (Stevens, 2009). The dependent variable in this analysis was
adherence to medications determined by whether or not a patient had refilled their
medication within at least a 6 month time frame. The possible predictor variables tested
in the analysis were age, gender, income, migrant worker status, family size, and health
education. A logistic regression analysis can be used when the predictor variables are
continuous, discrete, or a combination of continuous and discrete. Age was treated as a
discrete variable, divided into four categories: 1=18 to 30 years of age, 2=31 to 45 years
of age, 3=46 to 60 years of age, and 4=61 and older. Gender was categorized as males
versus females, health education, yes versus no, and migrant worker status yes versus no.
These were treated as dichotomous variables. Health education was determined by
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whether or not the patient took diabetes Type II health education classes. Income was
categorical dummy coded by the following classification 0= none, 1=$1 to $10, 000 per
year, 2=$10,001 to $15,000 per year, 3=$15,001 to 20,000 per year, and 4=$20,001 or
more. Family size was defined by the number of persons per household.
The logistic regression analysis permits the evaluation of the odds of membership
in adherence versus nonadherence based on the combination of predictor variables.
Overall model significance or the Omnibus test of model coefficients for the logistic
regression was examined by the effect of the predictor variables on adherence to
medication and were presented with an X² coefficient. The Cox and Snell R² and
Nagelkerke R² were used to examine the percent of variance accounted for the predictor
variables. Predicted probabilities of an event occurring were determined by the odds
ratio, Exp (β; Tabachnick & Fidell, 2012).
Logistic regressions overcome many of the restrictive assumptions of linear
regressions. Linearity, normality, and equality of variances are not assumed, nor is it
assumed that the error term variance is normally distributed. The major assumption of the
logistic regression is that the outcome variable must be discrete. The data should not
contain outliers, and there should be a linear relationship between the odds ratio and the
predictor variables (Tabachnick & Fidell, 2012). If there are any outliers, they should be
analyzed to determine if they represent unusual circumstances or if they are due to patient
error. Linearity with an ordinal or interval predictor variable and the odds ratio can be
checked by creating a new variable that divides the existing predictor variable into
categories of equal intervals and running the same regression on these newly categorized
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versions as categorical variables. Linearity is demonstrated if the B coefficient increases
or decreases the linear steps (Garson, 2009). Finally, a large sample is recommended
fitting with the maximum likelihood method; using discrete variables requires that there
are enough responses in each category. Table 1 will present the inclusion and exclusion
criteria for qualifying patients.

Table 1
Inclusion and Exclusion Criteria for Qualifying Patients From Which Data Were
Gathered
Inclusion

Exclusion

1.
2.
3.
4.

1. Patients with diabetes type I
2. Patients with gestational diabetes
3. Diabetes insipidus

Patient of Clinical Sierra Vista
Patients 18 years of age or older
Patients with diabetes type II
English or Spanish Speaking

Variables, Descriptions, and Measurements
Inferential statistics were used to predict an association between the independent
variables and the dependent variable: adherence to medications among Latinos with
diabetes Type II. The omnibus test of coefficients for the logistic regression was
examined by the effect of the predictor variables on adherences to medication and was
presented with an X² coefficient. The data collected related to Latinos, which are defined
as Mexican American, Mexican Migrant workers, Central American, South American,
Puerto Ricans, Cubans, Portuguese, or any individual with a Hispanic background. The
data were limited to patients who had identified their race as being Latino.
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The data were entered into a SPSS version 21.0 for Windows. Descriptive
statistics was conducted to describe the sample demographics and the research variables.
Frequency and percentages were calculated for gender, income, health education, family
size, and migrant worker status by adherence to medications. Means and standard
deviations were calculated for age and income by nonadherence to medications.
Screening of the data followed a statistical frequency distribution with cross tabulation
(Broeck, Cunningham, Eeckels, & Herbst, 2005).
Inferential Statistics
All variables were examined using the overall model of significance, or the
omnibus test of model coefficient, for the logistic regression and examined by the effect
of the predictor variable on adherence to medication and were presented with an X²
coefficient. The Cox and Snell R² and Nagelkerke R² were used to examine the
percentage of variances accounted for by the Exp (β; Tabachnick & Fedell, 2012). The
linearity with an ordinal, odds ratio and interval was used to determine if the B
coefficient increases or decreases with the maximum likelihood method.
Bivariate Analysis
Bivariate analyses, followed by multivariate analysis, were conducted to
determine an association between the independent variables and the dependent variable
of nonadherence to medications. The independent variables were gender, age, income,
health education, family size, and migrant worker status. The analyses were done in order
to answer the question:
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RQ1: Are there predictors of nonadherence to medications among Latinos with
diabetes Type II?
H01: There is not an association between age and nonadherence to medications
among Latinos with diabetes Type II.
Ha1: There is an association between age and nonadherence to medications among
Latinos with diabetes Type II.
H02: There is not an association between gender and nonadherence to medications
among Latinos with diabetes Type II.
Ha2: There is an association between gender and nonadherence to medications
among Latinos with diabetes Type II.
H03: There is not an association between income and nonadherence to
medications among Latinos with diabetes Type II.
Ha3: There is an association between income and nonadherence to medications
among Latinos with diabetes Type II.
H04: There is not an association between migrant workers and nonadherence to
medications among Latinos with diabetes Type II.
Ha4: There is an association between migrant workers and nonadherence to
medications among Latinos with diabetes Type II.
H05: There is not an association between family size and nonadherence to
medications among Latinos with diabetes Type II.
Ha5: There is an association between family size and nonadherences to
medications among Latinos with diabetes Type II.
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H06: There is not an association between health education and nonadherence to
medications among Latinos with diabetes Type II.
Ha6: There is an association between health education and nonadherence to
medications among Latinos with diabetes Type II.
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Table 2
Diabetes Type II Medication Nonadherence Independent Predicted Bivariate Variables
Null and Alternative Hypothesis (N=200)
Hypothesis

Concept

Name of variable

Possible outcome

Ho1:
There is not a statistically
significant association between
age and medication
nonadherence among Latinos
with diabetes type II.

Adherence to diabetes type II
medications in relation to age
groups.

Continuous predictor is Age

An association might
exist between age and
medication non
adherence in relation to
Latinos with diabetes
type II

Adherence to diabetes type II
medication for both males and
females

The predictor variable is gender

There is or is not
an association between
gender in relation to
adherences to diabetes
type II medications
among Latinos

Medication adherence to
diabetes type II regardless of
income

The predictor variable is income

There is or is not an
association between
income and medication
nonadherence among
Latinos with diabetes
type II.

Medication adherence to
diabetes type II in relation to
migrant worker status

The predictor variable is migrant
worker status

There is not
a strong association
between migrant worker
status and nonadherence
to diabetes type II
medications among
Latinos

Ha1:
There is a statistically significant
association
between age and medication
nonadherence among Latinos
with diabetes type II.
Ho2:
There is no statistically
significant association between
gender and medication
nonadherence among Latinos
with diabetes type II.

Ha2:
There is a statistically significant
association between gender and
medication nonadherence among
Latinos with diabetes type II.

Ho3:
There is no statistically
significant association between
income and nonadherences to
diabetes type II medication
Ha3:
There is a statistically significant
association between income and
nonadherences to diabetes type II
medications
Ho4:
There is no statically significant
association between migrant
worker status and nonadherences
among Latinos with diabetes type
II.
Ha4:
There is a statistically significant
association between migrant
worker and nonadherences
among Latinos with diabetes type
II.

69
Hypothesis

Concept

Name of variable

Possible outcome

Ho5:
There is no statistically
significant association between
family size and nonadherences
among Latinos with diabetes type
II.

Medication adherence to
diabetes type II in relation to
family size.

The predictor variable is family
size

There is or is not an
association between
family size and
adherences to diabetes
type II medications

Medication adherence to
diabetes type II in relation to
health education.

The predictor variable is health
education

There is or is not an
association between
health education and
adherences to diabetes
type II medications

Ha5:
There is a statistically significant
association between family size
and nonadherences among
Latinos with diabetes type II.

Ho6:
There is no statistically
significant association between
health education and
nonadherences among Latinos
with diabetes type II.
Ha6:
There is a statistically significant
association between health
education and nonadherences
among Latinos with diabetes type
II.

Multivariate Analysis
A multivariate analysis method was used to test the association between
medication nonadherence and a combination of two predictors to diabetes Type II among
Latinos.
RQ2: Is there a combination of predictors to nonadherence to medications among
Latinos with diabetes Type II?
H07: The combination of age and gender is not a strong predictor of nonadherence
to medications among Latinos with diabetes Type II.
Ha7: The combination of age and gender is a strong predictor of nonadherence to
medications among Latinos with diabetes Type II.
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H08: The combination of migrant workers and income is not a strong predictor of
nonadherence to medications among Latinos with diabetes Type II.
Ha8: The combination of migrant workers and income is a strong predictor of
nonadherence to medications among Latinos with diabetes Type II.
H09: The combination of age and health education is not a strong predictor of
nonadherence to medications among Latinos with diabetes Type II.
Ha9: The combination of age and health education is a strong predictor of
nonadherence to medications among Latinos with diabetes Type II.
H010: The combination of income and family size is not a strong predictor of
nonadherence to medications among Latinos with diabetes Type II.
Ha10: The combination of income and family size is a strong predictor of
nonadherence to medications among Latinos with diabetes Type II.
H011: The combination of gender and health education is not a strong predictor of
nonadherence to medications among Latinos with diabetes Type II.
Ha11: The combination of gender and health education is a strong predictor of
nonadherence to medications among Latinos with diabetes Type II.

71

Table 3
Multivariate Variables (N=200)
Hypotheses

Concept

Name of variable

Possible outcome

Ho7:
There is not a strong association
between the combination of age,
gender and adherence to diabetes
type II medications.

Age and gender in relation to
adherence to diabetes type II
medications.

The combination variables are
age and gender.

There is or
is not a
strong
association
between
diabetes
type II and a
combination
of age and
gender
among
Latinos.

Adherence to diabetes type II
medications in relation to
migrant worker status and
income.

The combination predictor
variables are income and migrant
worker status.

There is or is not a
strong predictor value
associated with
nonadherence to
diabetes type II
among Latinos.

Health education and age in
relation to diabetes type II
medications.

The combination predictor
variables are health education and
age.

There is or is not a
strong predictor value
of the combined
variables associated
with adherences or
nonadherences.

Family size and income in
relation to diabetes type II
medications.

The combination predictor
variables are family size and
income.

There is or is not a
strong predictor value
of the combined
variables associated
with adherences or
nonadherences.

Ha7:
There is a strong association
between the combination of age,
gender and adherence to diabetes
type II medications

Ho8:
The combination of migrant
workers status and income are not
strong predictors to adherence of
diabetes type II medications.
Ha8:
The combination of migrant
workers status and income are
strong predictors to adherence of
diabetes type II medications.
Ho9:
Health education and age are not
strong predictors to diabetes type
II medication adherences.
Ha9:
The combination of health
education and age are strong
predictors to diabetes type II
medication adherences.

Ho10:
Family size and income are not
strong predictors to diabetes type
II medication adherences.
Ha10:
Family size and income are strong
predictors to diabetes type II
medication adherences.

Table Continues
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Ho11:
Gender and health education are
not strong predictors to diabetes
type II medications adherences.

Gender and Health education
in relation to diabetes type II
medications.

The combination predictor
variables are gender and health
education

Ha11:
The combination of gender and
health education are strong
predictors to diabetes type II
medication adherences

There is or is not a
strong predictor value
of the combined
variables associated
with adherences or
nonadherences.

The independent variables were age, gender, income, health education, family
size, and migrant worker status as predictors to medications nonadherence to be selfcompleted and self-reported. These forms included personal information, demographics,
resources, and medical history. The PSR are available to assist patients who speak
languages other than English by providing translators. The information collected was
stored using “i2i Media Tracks.” The staff is trained to treat the data collected with the
upmost sensitivity and confidentiality, regardless of patient’s insurance or income status.
The patient’s information is maintained using the Health Insurance Portability and
Accountability Act of 1996. The data are self-reported by the patient at the time of the
medical visit. Once the information is in the system, the data are updated at time of each
recurrent visit by the trained staff at Clinica Sierra Vista in Fresno, California.
Table 4
Omnibus Test of Model Coefficient Using SPSS

Step 1

Step
Block
Model

Chi-Square

df

Sig

Numbers
Numbers
Numbers

5
5
5

.000
.000
.000
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Table 5
Model Summary
Step

.2 Log Likelihood

1

Cox & Snell R² Nagelkerke R²

Numbers

Numbers

Numbers

Table 6
Variables in Model

Step 0 1

B

SE

Wald

df

Sig

Exp (β)

()

()

()

1

()

()

Data Analysis Matrix
The data are stored on servers at Clinica Sierra Vista. The “i2i Media Tracks”
contains over 14, 000 active patients suffering from diabetes Type II. The majority of the
population was Latinos from the different areas of Fresno. There are eight clinics in
Fresno servicing the community. A letter permitting use of Clinica Sierra Vista data files
were authorized by the administrators (see Appendix A). The administrators have been
helpful as long as patient confidentiality is maintained. See Table 7:
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Table 7
Analysis Matrix for the Quantitative Retrospective Research Study Between Medications
Nonadherences Among Latinos With Diabetes Type II (N = 200)
Study

Concept

I

Study of population
adherences to
diabetes type II
medications

I.1

Study of
demographics of
individuals in
relation to adherence
to diabetes type II
medication
Study of a
combination of
demographics in
relation to adherence
to diabetes type II
medication

I.2

Data

Measurement

Data analysis
and statistics

Medical chart
review and
electronic
medical record
review
Medical chart
review and
electronic
medical record
review

Ordinal,
quantitative,
dichotomous,
continuous,
categorical
Ordinal,
quantitative,
dichotomous,
continuous,
categorical

Mean, standard
deviation,
percentage and
frequency

Medical Chart
review and
electronic
medical record
review

Ordinal,
quantitative,
dichotomous,
continuous,
categorical

Mean, standard
deviation,
percentage and
frequency

Mean, standard
deviation,
percentage and
frequency

Threats to Validity
The use of quantitative retrospective design archive data leads to threats to
external validity (Garcia-Perez, 2012). Gathering the right sample is important in order to
determine the accuracy of the population with diabetes Type II among Latinos.
Historical accuracy of the data collected will decrease the threat to external and internal
validity, increasing the reliability of the data. Therefore, the research study reliability will
improve the possibility of providing programs to help Latinos with diabetes Type II in
Fresno, California.
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Statistical regression is a possible threat to interval validity with a nonrandom
sample, such as in the case of secondary data analysis and two measurements that have
no association. In this phenomenon, the statistical regression occurs causing a threat to
the internal validity and reliability of the study (Weisstein, 2013). Accuracy of the data
may also be skewed by the possibility of patients providing inaccurate data due to reasons
such as distractions from other patients in the same room, feeling rushed in order to see a
physician sooner, and trying to protect their reputation in their community.
Ethical Procedures
Clinica Sierra Vista provided a letter granting access to the archival data on
September, 2012. The letter was signed by the deputy chief of programs and by the chief
administrative officer, permitting the use of the aggregate data containing over 14,000
active patients suffering from diabetes Type II. The database contains a lot of data with
multiple variables including, but not limited to patients’ demographics, principal
language spoken at home, and income. Clinica Sierra Vista as a stakeholder was
committed to the success of the research study. See permission letter (Appendix A). All
data were recognized as requiring confidentiality under the Health Insurance Portability
and Accountability Act (HIPAA) and the National Institute of Health (NIH) web-based
training course Protecting Human Research Participants (Appendix B) certificate of
completion dated 9/24/2011. This requirement was met fully including Clinica Sierra
Vista policies and procedures relating to patient confidentiality. The data gathered did not
include names of patients pulled for research. All identifiers were removed from the
database. The data were collected from the “i2i media tracks” electronic medical records.
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Walden University requirements were met. The data collected were archived data
from Clinica Sierra Vista database files. There was no risk to the participants. No data
analysis was performed or collected without the IRB approval. Once permission was
given, the data were entered into the electronic SPSS software. Once the data were
entered, it will be managed with the outmost integrity and accuracy and deleted after 6
years using a Zip archive folder to protect the files. I submitted an IRB application as per
university regulations. Data was collected after given IRB approval to conduct the study
(Walden IRB approval number is 02-26-14-0182422).
Summary
Chapter 3 contains information relating to the research design, the methodology,
the population, sample size, and data collection. The chapter also includes information
regarding internal as well as external threats to validity, accuracy, and data integrity.
Another area discussed in this chapter relates to permissions and requirements when
working with archived data, protection of human subjects, and IRB approval for data
analysis. Chapter 4 will include the data collection, analysis, and interpretation of the
data.
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Chapter 4: Results
Introduction
The purpose of the research study was to understand the barriers to medication
nonadherence among Latinos with diabetes Type II using the independent variables of
age, gender, income, migrant worker status, family size, and health education. These
sociodemographic variables may predict an association to diabetes Type II medication
adherence among Latinos (the dependent variable). The research questions and
hypotheses were as follows:
RQ1: Are there predictors of nonadherence to medications among Latinos with
diabetes Type II?
H01: There is not an association between age and nonadherence to medications
among Latinos with diabetes Type II.
Ha1: There is an association between age and nonadherence to medications among
Latinos with diabetes Type II.
H02: There is not an association between gender and nonadherence to medications
among Latinos with diabetes Type II.
Ha2: There is an association between gender and nonadherence to medications
among Latinos with diabetes Type II.
H03: There is not an association between income and nonadherence to
medications among Latinos with diabetes Type II.
Ha3: There is an association between income and nonadherence to medications
among Latinos with diabetes Type II.

78
H04: There is not an association between migrant workers and nonadherence to
medications among Latinos with diabetes Type II.
Ha4: There is an association between migrant workers and nonadherence to
medications among Latinos with diabetes Type II.
H05: There is not an association between family size and nonadherence to
medications among Latinos with diabetes Type II.
Ha5: There is an association between family size and nonadherence to
medications among Latinos with diabetes Type II.
H06: There is not an association between health education and nonadherence to
medications among Latinos with diabetes Type II.
Ha6: There is an association between health education and nonadherence to
medications among Latinos with diabetes Type II.
RQ2: Is there a combination of predictors to nonadherence to medications among
Latinos with diabetes Type II?
H07: The combination of age and gender is not a strong predictor of nonadherence
to medications among Latinos with diabetes Type II.
Ha7: The combination of age and gender is a strong predictor of nonadherence to
medications among Latinos with diabetes Type II.
H08: The combination of migrant workers and income is not a strong predictor of
nonadherence to medications among Latinos with diabetes Type II.
Ha8: The combination of migrant workers and income is a strong predictor of
nonadherence to medications among Latinos with diabetes Type II.
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H09: The combination of age and health education is not a strong predictor of
nonadherence to medications among Latinos with diabetes Type II.
Ha9: The combination of age and health education is a strong predictor of
nonadherence to medications among Latinos with diabetes Type II.
H010: The combination of income and family size is not a strong predictor of
nonadherence to medications among Latinos with diabetes Type II.
Ha10: The combination of income and family size is a strong predictor of
nonadherence to medications among Latinos with diabetes Type II.
H011: The combination of gender and health education is not a strong predictor of
nonadherence to medications among Latinos with diabetes Type II.
Ha11: The combination of gender and health education is a strong predictor of
nonadherence to medications among Latinos with diabetes Type II.
Chapter 4 is divided into four sections. The introduction contains a brief
description of the purpose, research questions, and hypotheses. The data collection
includes the timeframe, variables, and types of analysis that was done. The results include
data analysis and findings consisting of descriptive and inferential statistics. The results
include bivariate and multivariate analysis. In the summary, I answer the research
question and prescriptive material.
Data Collection
The study was a quantitative retrospective data method design. I conducted a
secondary data analysis performed from the database files at Clinica Sierra Vista linked
to i2i Media Tracks that serves eight clinics from rural, suburban, and urban
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impoverished areas of the city. The data gathered were from 2010 to 2014. The data were
collected and analyzed between March and May 2014. The data were analyzed to
understand the association between the sociodemographic independent variables of age,
gender, income, migrant status, family size, and health education, including the
dependent variable adherence to medications among Latinos with diabetes Type II. A
bivariate analysis for each independent variable was tested to see if there was an
association between the independent variables and the dependent variable. The
multivariate analysis method identified strong predictor values of any combination of the
six independent variables in relation to diabetes Type II among Latinos. The original plan
was to analyze data varying from 2008 to 2012; however, I found that there were
insufficient electronic data available prior to 2010. The number of patients from 2008 and
2009 combined were less than 40; however, it was specified that 40 patients per year over
a 5-year span was necessary to equate to 200 patients for this study. Therefore, the study
was adjusted to include data spanning from 2010 to 2014. As the data were analyzed, it
was noted that family size could have had an impact on how income is dispersed within a
household. Family size was thus added as an additional independent variable.
Study Sample
Descriptive statistics analysis was conducted to describe the sample demographics
and the research variables. Frequency and percentages were calculated for age, gender,
income, health education, family size, and migrant worker status by nonadherence to
medications. Means and standard deviations were calculated for age and income by
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nonadherence to medications. Screening of the data followed a statistical frequency
distribution with cross tabulation (Broeck et al., 2005).
Results
The frequencies and percentages related to diabetes Type II from highest to
lowest by age was 46 to 60 years of age, 31 to 45 years of age, 60 years and over, and 18
to 30 years of age. Diabetes Type II was less frequent among younger people in the
sample. The distribution of the subjects with diabetes Type II by gender was females
70% and males 30%. Frequencies of patients with diabetes Type II by the independent
variable income was described from highest to lowest $1.00 to $10,000, followed by
$10,001 to $15,000, $20,001 and over, and lastly $15,001 to $20,000. The frequency of
income could be affected by the fact that the majority of residents of Fresno County are
impoverished and under the federal poverty level according to the 2012 guidelines.
Specifically, 79.5% of patients were migrant workers versus 20.5% who were not. This
correlates with frequencies of income; migrant workers tend to be more impoverished. I
found that 65.5 % of patients took health education classes whereas 34.5% did not.
Patients’ family size ranked highest to lowest were families with two to four members,
one member, and five or more members in the home. Table 8 presents the demographics
of the population.
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Table 8
Frequency and Percent Distribution of Selected Demographic Characteristics of the
Study Subjects Using the SPSS (N = 200)

Category
Age
18-30
31-45
46-60
61-over
Total
Gender
Males
Females
Total
Income
1-10,000
10,000-15,000
15,001-20,000
20,000+
Total
Migrant worker status
Yes
No
Health education
Yes
No
Total
Family size
1
2-4
5 and up

Frequency

Percentage

7
51
92
50
200

3.5
25.1
46.0
25.0
100

60
140
200

30
70
100

86
57
19
38
200

43.0
28.0
9.5
19.0
100

159
41

79.5
20.5

131
69
200

65.5
34.5
100

69
92
39

34.5
46
19.5

Total

200

100

Rates of medication nonadherence for patients diagnosed with diabetes Type II
among Latinos were almost evenly distributed as 53.5% who adhered versus 46.5 % who
did not adhere among Latinos with diabetes Type II. See Table 9 and Table 10:
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Table 9
Frequency and Percent Distribution of Medications Nonadherence Among Study Subjects
(N = 200)

Frequency

Percentage

Medication nonadherence

Total:

No

93

46.5

Yes

107

53.5

200

100.0
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Table 10
Bivariate Omnibus Test Results Using SPSS (N=200)
df

X²

Cox &
Snell R²
.001

Nagelkerke
R²
.002

P

OR

Age &
4
.279
.598
.911
nonadherence
Gender &
1
7.734
.038
.051
.005*
.413
nonadherence
Income &
4
.001
.000
.000
.982
1.003
nonadherence
Migrant
1
.001
.000
.000
.982
1.008
worker &
nonadherence
Health
1
4.510
.022
.030
1.900
.034*
education &
nonadherence
Family Size & 3
.952
.005
.006
.329
.869
nonadherence
Note. Odds ratios were calculated using a 95% confidence interval. An alpha level of
0.05 was used
*Shows a moderate association to nonadherence to medications among Latinos with
diabetes Type II.
Research Question 1
1.

Are there predictors of nonadherence to medications among Latinos with
diabetes Type II?

The odds ratio for the association between age and nonadherence to medications
was calculated to 0.911 with a p value of 0.598. For the age group 18 to 30 years, 85.7%
of patients did not adhere and 14.3% adhered to medications (n = 7; 3.5%). For the age
group 31 to 45 years, 53.9% showed nonadherence to diabetes Type II medications and
47.1% adhered to medications (n = 51; 25%). Patients between the ages of 46 to 60 had
an adherence rate of 50% and a nonadherence rate of 50% to medications (n = 92;
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25.5%). Patients 60 years of age and older showed an adherence of 44% and a
nonadherence rate of 56% to medications (n = 50; 25.0%). I accepted the null hypothesis
because the p value is significantly greater than 0.05. There is not an association between
age and nonadherence to medications among Latinos with diabetes Type II.
The odds ratio for the association between gender and nonadherence to diabetes
Type II medications among Latinos was calculated to 0.413 with a p value of 0.005.
Because the p value calculated is less than 0.05, I rejected the null hypothesis. There is an
association between gender and nonadherence to medications among Latinos with
diabetes Type II.
The odds ratio for the association between income and nonadherence to diabetes
Type II medications among Latinos was calculated at 1.003 with a p value of 0.982.
Income was divided into four categories. The categories were chosen starting at $1 to
$10,000 and incrementing $5,000 per category to represent the 2012 Federal Poverty
Measurements of the impoverished areas in Fresno County. The first category $1 to $10
000 showed adherence of 47.7% and nonadherence of 52.3% (n = 86; 43%). The second
category $10,000 to $15,000 showed a medication adherence of 42.1 % and
nonadherence of 57.9% (n = 57; 28.5%). The third category $15,000 to $20,000 showed a
statistical analysis of medication adherence of 57.9% and a medication nonadherence of
42.1% (n = 19; 9.5%). The fourth category included $20,000 and over and showed
statistical analysis for medication adherence of 44.7% and nonadherence of 55.3% (n =
38; 19%). The p value calculated greater than 0.05. Therefore, I accepted the null

86
hypothesis. There is no association between income and nonadherence to medications
among Latinos with diabetes Type II.
The odds ratio in association to migrant worker status and nonadherence to
diabetes Type II medications among Latinos with diabetes Type II was calculated to
1.008 with a p value of 0.982. The p value calculated greater than 0.05. Therefore, I
accepted the null hypothesis. There is not an association between migrant worker status
and nonadherence to medications among Latinos with diabetes Type II.
The odds ratio in association to family size and nonadherence among Latinos with
diabetes Type II calculated to 0.869 with a p value of 0.329. Family size was grouped by
individuals per household. Groups were divided as one person, two to four persons, and
five or more persons. A family size of one had a medication adherence of 42% and a
medication nonadherence of 58% (n = 69; 34.5%). A family size of two to four persons
had a medication adherence of 48% and a medication nonadherence of 52% (n = 92;
46%). A family size of five or more had a medication adherence of 51% and a medication
nonadherence of 49% (n = 39; 19.5%). The p value is greater than 0.05. Therefore, I
accepted the null hypothesis. There is no association between family size and
nonadherence to medications among Latinos with diabetes Type II.
The odds ratio in association to health education and nonadherence to diabetes
Type II medications calculated to 1.900 with a p value of 0.034. The p value is less than
0.05. Therefore, I rejected the null hypothesis. There is an association between health
education and nonadherence to medications among Latinos with diabetes Type II. See
Table 11:
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Table 11
Multivariate Omnibus Test Results for all Variables Using SPSS (N=200)
Df

p

OR

Age

4

.745

1.063

Gender

1

.012

2.301

Income

4

.995

1.001

Migrant worker

1

.967

1.015

Health education

1

.049

.538

Family size

3

.329

.869

Constant

1

.237

.441
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Table 12
Multivariate Omnibus Test Results for Combinations of Variables (N=200)
df

Wald

X²

Cox &
Snell R²
.038

Nagelkerke
R²
.051

p

OR

Age, gender &
2
.064
7.798
.955
.020*
nonadherence
7.191
.417
Migrant worker, 2
.001
.001
.000
.000
.999
1.003
income &
.001
1.009
nonadherence
Age, health
2
.261
4.771
.024
.031
.092
.912
education &
4.397
1.898
nonadherence
Income, family 2
.219
1.172
.006
.008
.323
.937
size &
1.165
1.265
nonadherence
Gender, health
2
6.991 11.809 .057
.077
.420
.003*
education &
3.998
1.862
nonadherence
Note. Odds ratios were calculated using a 95% confidence interval. An alpha level of
0.05 was used.*Shows a strong association to nonadherence to medications among
Latinos with diabetes Type II. Odds ratios were calculated using a 95% confidence
interval.
Research Question 2
2.

Is there a combination of predictors to nonadherence to medications
among Latinos with diabetes Type II?

The combination of age and gender is a strong predictor to nonadherence to
medications among Latinos with diabetes Type II. The odds ratio was calculated at 0.955
and gender at 0.417 with a p value of 0.020. Because the P value is less than 0.05, I
rejected the null hypothesis. The combination of age and gender is a strong predictor to
diabetes Type II medications among Latinos.
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The odds ratio between migrant worker status and income as a predictor to
medication nonadherence among Latinos with diabetes Type II was calculated at 1.009
for migrant workers and at 1.003 for income with a p value of 0.999. The p value is
greater than 0.05. Therefore, I accept the null hypothesis. There is not a strong
association between migrant worker status and income associated with diabetes Type II
among Latinos.
The odds ratio for the combination of age and health education was calculated at
.912 for age and 1.009 for health education with a p value of 0.092 greater than the
normal p value of 0.05. Therefore, I accepted the null hypothesis. The combination of age
and health education is not a strong predictor of nonadherence to medications among
Latinos with diabetes Type II.
The combination of income and family size is not a strong predictor of
nonadherence to medications among Latinos with diabetes Type II. The odds ratio was
calculated for income at 0.937 and at 1.265 for family size with a p value of 0.323 greater
than the normal p value of 0.05. Therefore, I accepted the null hypothesis. There is no
association between the combination of income and family size and nonadherence to
medications among Latinos with diabetes Type II.
The odds ratio for the combination of gender and health education was calculated
at 0.420 for gender and 1.862 for health education with a p. value of 0.003. Because the
value is less than the normal p value of 0.05, I rejected the null hypothesis. The
combination of gender and health education is a strong predictor of nonadherence to
medications among Latinos with diabetes Type II, rejecting the null hypothesis.
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Summary
I found that gender is the only strong predictor of nonadherence to medications
for Latinos with diabetes Type II. Out of the patients who were randomly selected, the
majority of them were women, which could pose as a limitation to the study. However, a
higher percentage of women adhered to medications as compared to the percentage of
men who adhered. Further investigation would have to be done as to why women are
more likely to adhere than men. The combination age, gender and gender, health
education proved to be strong predictors to nonadherence to medications for Latinos with
diabetes Type II. Chapter 5 includes the interpretation of the findings, limitations of the
study, and recommendations.
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Chapter 5: Discussion, Conclusions, and Recommendations
The purpose of the research study was to explore the association between the
dependent variable adherence to medications among Latinos with diabetes Type II and
the sociodemographics independent variables age, gender, income, migrant worker status,
family size, and health education to determine if there are predictors of nonadherence to
diabetes Type II medications among Latinos with diabetes Type II. I analyzed the data
from 200 males and females patients 18 years of age and older diagnosed with diabetes
Type II from a clinic linked to i2i Media tracks that serves eight clinics from rural,
suburban, and urban impoverished areas of the city. The research was guided using the
SDT and the social cognitive theory. The independent variable showed that health
education and gender each showed an association with medication nonadherence among
Latinos with diabetes Type II compared to the other variables when a p value threshold of
.05 was employed; however, after applying the Bonferroni adjustment value, they proved
to be significant only when studied in combination.
Interpretation of the Findings
RQ1: Are there predictors of nonadherence to medications among Latinos with
diabetes Type II?
Finding 1: Age and Nonadherence
I found that there was no association between age and nonadherence to
medications among Latinos with diabetes Type II. The adherence rates were 46.5%
among Latinos with diabetes Type II with a nonadherence rate of 53.5%. For the age
group 18 to 30 years, 85.7% of patients did not adhere and 14.3% adhered to medications
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(n = 7; 3.5%). For the age group 31 to 45 years, 53.9% showed nonadherence to diabetes
Type II medications and 47.1% adhered to medications (n = 51; 25%). Patients between
the ages of 46 to 60 had an adherence rate of 50% and a nonadherence rate of 50% to
medications (n = 92; 25.5%). Patients 60 years of age and older showed an adherence of
44% and a nonadherence rate of 56% to medications (n = 50; 25.0%). The average age of
individuals with diabetes type II among Latinos was calculated at 54.7 years of age. The
statistical analysis for the combined test model showed that there is not a significant
association between age and nonadherence to medications among Latinos with diabetes
Type II. The overall Omnibus Test of Model Coefficients yielded an overall (chi-square =
0.279; p = .598; OR = .911). The overall Omnibus Test of Model Coefficient Odds Ratio
was .911 and the p value was .598. Therefore, there was no association between age and
nonadherence to medications among Latinos with diabetes Type II. Nozaki et al. (2009)
found that there was an association between age and medication adherence. However,
Nozaki et al. did not include a percentage distribution of age groups, making it difficult to
compare the statistical findings per age group. Among the age groups, there was a
correlation between age and nonadherence to medications. The p value was greater than
0.05 and the odds ratio was .911, which indicates that there was no association to the
outcome adherence.
Finding 2: Gender and Nonadherence
There was a weak to moderate association between gender and nonadherence to
medications among Latinos with diabetes Type II. The overall omnibus test of Model
Coefficients for gender yielded a (chi-square = 7.734; p = 0.005; OR = 0.413). Males
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showed an adherence rate of 31.7% and a nonadherence rate of 68.3% (n = 60; 30%). I
found that the male gender nonadherence was high. The adherence rate for females was
52.9% to medications among Latino females with diabetes Type II and a nonadherence
rate of 47.1% (n = 140; 70%). The results of the study indicate that there is an association
to the outcome variable of adherence and a weak association between gender and
nonadherence between medications among the Latino female group. The study resulted in
70% of participants being female and 30% males. This mirrors the distribution of gender
for patients studied by Mann et al. (2009) who reported that 68% of patients in the study
were female. Mann et al. was also not able to conclude a strong correlation between
gender and medication nonadherence among Latinos with diabetes Type II. White et al.
(2011) used the Spearman correlation coefficient (p) values to test bivariate associations
between DNT-15 Latino and sociodemographics, gender, nationality, language, education
level, and health history regarding diabetes Type II, including insulin. The DNT-15
Latino tool measurement was significantly associated with females generally being more
likely to seek out medical care than males. Giving these findings, it may be worth
investigating ways to encourage males to seek medical attention through national
campaigns or public announcements. It is important to find alternative means to motivate
the male Latino patient with diabetes to improve adherence to medications, diet, and
exercise. Rustveld et al. (2009) found that self-esteem and a sense of powerlessness can
affect Latino American men with diabetes Type II.
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Finding 3: Income and Nonadherence
I found that there was not a significant association between income and
nonadherence to medications among Latinos with diabetes Type II. The overall Omnibus
Test of Model Coefficients for income yielded a (chi-square = 0.001; p = .982; OR =
1.003). The overall adherence rate was 46.5% and medication nonadherence 53.5%.
The average income was calculated at $10,225. Categories were chosen starting at $1 to
$10,000 and incrementing $5,000 per category to represent the 2012 Federal Poverty
Measurements of the impoverished areas in Fresno County. The first category $1 to $10,
000 showed adherence of 47.7% and nonadherence of 52.3% (n = 86; 43%). The second
category $10,000 to $15,000 showed a medication adherence of 42.1 % and a
nonadherence of 57.9% (n = 57; 28.5%). The third category $15,000 to $20,000 showed a
statistical analysis of medication adherence of 57.9% and medication nonadherence of
42.1% (n = 19; 9.5%). The fourth category included $20,000 and over and showed
statistical analysis for medication adherence of 44.7% and nonadherence of 55.3% (n =
38; 19%). Income and nonadherence p value .982 and the OR value 1.003 indicate that
there is not an association to income and nonadherence to medication among Latinos
with diabetes Type II. The OR is closer to 1, however, the p value is greater than 0.05.
The OR results of 1.003 indicate that there is a weak association to the outcome
adherence. Hence, the research findings are similar to the research study conducted by
Mann et al. (2009) who reported the predictor income and found it to be inconsistent due
to variations in study designs and sample populations. Mann et al. reported that 89% of
participants had an income level of less than $30,000. Mainous et al. (2008) found that
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Latinos with diabetes Type II with less acculturation showed an annual income of less
than $20,000 and were less likely to have completed high school. The studies are similar
to the income distribution in this study where 81% of participants had an income level
less than $20,000. Thus, this finding correlates to what Mann et al. and Mainous et al.
had previously demonstrated. The study population consisted of individuals from
impoverished areas of Fresno County who traveled to different areas of the state and to
other states looking for employment as migrant farm workers. Many of these individuals
have a difficult time meeting their daily health care and medication responsibilities.
Finding 4: Migrant Worker Status and Nonadherence
There was not a significant association between migrant worker status and
nonadherence to medications among Latinos with diabetes Type II. The overall Omnibus
Test of Model coefficients yielded a (chi-square = .001; p = .982; OR = 1.008). Migrant
worker status statistical analysis showed an adherence of 46.5% and nonadherence of
53.5% (n = 159; 79.5%). Migrant worker status did not show a statistical significance to
medication nonadherence. This finding is surprising because migrant workers travel from
state to state for extended periods of time within the year, making it difficult to get their
medications when out of the residency state. I have observed that some migrant workers
will plan ahead to ensure that they have sufficient medications while they are away,
requesting a 90-day supply of medication. However, they might run out of medication if
their assignment is for more than 6 months, or they might still forget to take their
medications while they are away. Migrant worker status was not identified in the
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literature. Therefore, further research is needed to explore motivational means of
increasing adherence among Latino male migrant workers with diabetes Type II.
Finding 5: Family Size and Nonadherence
There was not a significant association between family size and nonadherence to
medications among Latinos with diabetes Type II. The overall Omnibus Tests of Model
Coefficients rate for family size yielded a (chi-square = .952; p = .329; OR = .869). The
overall logistic regression results for family size was medication adherence 46.5% and
medication nonadherence was 53.5%. A family size of one had a medication adherence
of 42% and a medication nonadherence of 58% (n = 69; 34.5%). A family size of two to
four had a medication adherence of 47.8% and a medication nonadherence of 52.2% (n =
92; 46%). A family size of five or more had a medication adherence of 51.3% and a
medication nonadherence of 48.7% (n = 39; 19.5%). The family size and nonadherence p
value was .329 and the odds ratio was .869. The values indicate that there was no
association to the outcome adherence. There has been no previous study on the
correlation of family size to medication nonadherence among Latinos with diabetes Type
II. Based on the results of this study, family size may be included as a predictor variable
in future research studies.
Finding 6: Health Education and Nonadherence
Health education had a statistical association to nonadherence to medications
among Latinos with diabetes Type II prior to applying the Bonferroni adjustment. When
using the alpha value .05, the results showed a p value of .034 with an odds ratio of 1.9,
which may indicate that there is a strong association. The Omnibus Tests of Model of
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coefficients was (chi-square = 4.510; p = .034; OR = 1.900). Patients who had health
education classes had an overall adherence rate of 51.9% and a nonadherence of 48.1% (n
= 131; 65.5%). Out of the 200 patients, 69 did not attend the educational classes and 131
patient attended health educational classes. Patients who take education classes are
probably more likely to adhere to medications. Mann et al. (2009) reported that health
education from the participants’ point of view was not given in a way they could
understand or comprehend what was being taught. Because this might have been the case
in this study, it may be worth the effort to alter the ways health education is provided to
patients with language barriers, limited education, limited knowledge of diabetes Type II,
and limited resources including transportation and health care insurance so that more
patients can have access to health education. Patients should also be encouraged to bring
family members to the health educational classes in order to remind them or aid in their
understanding of what has been taught. Health education awareness is important in
patients self-managing diabetes Type II, which includes blood glucose testing,
understanding of how to take by mouth medications or inject insulin, knowing critical
blood glucose levels results, and sticking their finger to find blood glucose level before
and after a meal. The WHO (2003) noted that health education is not only for patients but
clinicians as well to be able to deliver similar protocols where both the clinician and the
patient are ready for adherence supported by a health delivery system.
Finding 7: Age, Gender, and Nonadherence
The combination of age and gender were strong predictors to medication
nonadherence among Latinos with diabetes Type II using the alpha p value of .05. The
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Logistic Regression Omnibus Tests of Model Coefficients statistic analysis yielded an
overall (chi-square = 7.798; p = 0.020; OR = 0.955/0.417). Nozaki et al. (2009) reported
that more logistic regression analysis studies are needed in the future using
sociodemographics, age, and gender. The results of this finding may corroborate the
study findings of Nozaki et al. Age and gender are predictors to medication nonadherence
using the alpha value of 0.05. The information can assist researchers in deciding the
importance of the predictor variables of sociodemographics, age, and gender for future
studies.
Finding 8: Income, Migrant Worker Status, and Nonadherence
The combination of income and migrant worker status was not a strong predictor
of medication nonadherence among Latinos with diabetes Type II. The Logistic
Regression Omnibus Test of Model Coefficients was (Chi-square = .001; p = .999; OR =
1.003/1.009). Based on my experience of working with diabetic patients, I expected that
patients’ nonadherence to medications would be related to income and migrant worker
status. However, the study findings showed that the combination of income and migrant
worker status was not a strong predictor to medication nonadherence. Future studies are
needed using the combination variables income and migrant worker status. There are
many other factors that limit income and migrant worker status in maintaining adherence
to diabetes Type II medications, such as time away from home, values and beliefs about
nutrition while working, and exposure to health education.
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Finding 9: Age, Health Education, and Nonadherence
The combination of age and health education was not a strong predictor of
medication nonadherence among Latinos with diabetes Type II. The Logistic Regression
Omnibus Tests of Model Coefficients was calculated an overall (Chi-square = 4.771; p =
.092; OR = .912/1.898). There have been no previous studies done that combined
variables similar to this study to identify strong predictors to medication nonadherence
among Latinos with diabetes Type II. Therefore, the results of this study may be used for
future research using the combination variables as used in this study.
Finding 10: Income, Family Size, and Nonadherence
There was no association between the combination of income, family size, and
adherence to medications. The combination of income and family size was not a strong
predictor of nonadherence to medications among Latinos with diabetes Type II. The
overall Logistic Regression Omnibus Tests of Model Coefficients yielded a (chi-square =
1.172; p = .323; OR = .937/1.265). Because the combination variable income and family
size have not been studied, future research is needed to determine whether family size
combined with income is a predictor to medication nonadherence among Latinos with
diabetes Type II.
Finding 11: Gender, Health Education, and Nonadherence
The combination of gender and health education was a strong predictor of
nonadherence to medications among Latinos with diabetes Type II. Because gender and
health education were strong predictors when they were analyzed individually, it is not
surprising to see gender and health education combined to be a strong predictor of
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medication nonadherence among Latinos with diabetes Type II. The overall Logistic
Regression Omnibus Test of Model Coefficients calculated (chi-square = 11.809; p =
.003; OR = .420/1.862). Health education should be instructed in a way that meets the
needs of the individual patient, taking into account the patient’s workplace, work away
from home, and nutrition while away from home including drinks. Health educators play
an important role as part of the health care team. Health education should be altered,
teaching about glucose levels before and after nutrition. Patients should be empowered to
perform finger sticks at home before and after meals to prevent hypoglycemia and
hyperglycemia reactions in blood glucose levels. It is worth altering health education to
make it more appealing for males, while keeping it appealing for females. It is important
to teach patients how to maintain hydration without the use of alcohol beverages and diet
using the recommended diet by the American Diabetes Association and the Centers for
Disease Control and Prevention.
The data analysis included a descriptive and inferential statistical analysis of the
association between the independent variables of age, gender, income, migrant worker
status, family size, health education, and the outcome of medication adherence. I found
that 93 patients (46.5%) were adherent to medications among Latinos with diabetes Type
II, and 107 patients (53.5%) were nonadherent to medications among Latinos with
diabetes Type II. Nonadherence is defined as a prescription or recommendation from a
clinician not followed by a patient. My findings contradict Parada et al. (2012) who
demonstrated that, out of 302 patients, 60% of Latinos with diabetes Type II were
nonadherent to medications. Wabe et al. (2011) indicated that the worldwide adherence
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rate of diabetes Type II medications was approximately 36% to 93%, depending on the
demographics and socioeconomic status of the individual. In Fresno County, the
nonadherence rate was 53.5% for this study, and thus 46.5% of patients who adhered,
demonstrating a lower adherence rate to medications among Latinos with diabetes Type
II. Only a few sociodemographics predictors proved to have a strong association to
medication nonadherence among Latinos with diabetes Type II.
Limitations of the Study
One of the original limitations of this study was that some patients may not have
identified themselves as being Latino; as a result, potential participants may not have
been included in the study. It was assumed that most Latino subjects did identify
themselves as Latinos. As the data were gathered, there was no way to determine whether
or not patients had identified themselves incorrectly; thus, I could not determine whether
it truly affected the result of this study.
The study participants were randomly chosen using a random number generator
from the archived data base. More women than men were selected. Because gender
proved to be a strong predictor of medication nonadherence among Latinos with diabetes
Type II, selection bias could have been present secondary to limited access to data.
Recommendations
The study results indicated that only gender and health education are strong
predictors to the outcome dependent variable of adherence. Therefore, further study is
needed to identify additional variables as possible predictors. It is the responsibility of
clinicians to teach personalized health education classes. However, it is also the
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responsibility of the patient to attend health education classes. Hospitals, clinics, as well
as independent physicians or health educators must follow a protocol of teaching patients
about diet, alcoholic beverages, exercise, medications, and the effects these have on
diabetes prevention and management. Health education may assist in increasing
awareness of self-management.
Because more females than males were randomly selected for the study, I
recommend that females and males ought to be studied as separate entities. Additional
recommended variables may pertain specifically to diet, for example, number of
alcoholic beverages per week, the number of sodas per week, carbohydrate intake, and
sugary treats.
Diabetes Type II is without symptoms with the exception of hyperglycemia
causing polyuria, polyphagia, and polydypsia. Therefore, the health care team must
encourage daily glucose testing to allow the patient to know his/her daily glucose level
and understand the need for medication, diet, and exercise. A proactive approach will
decrease cultural beliefs relating to causes of diabetes Type II, strengthening the value of
diabetes Type II self-management. These opportunities will improve adherence to
medication, promote open communication with the patient’s primary medical provider,
increase adequate diet and exercise, and maintain regular appointments with a medical
provider.
Implications to Social Change
Swan (2010) explained that helping patients understand their barriers to diabetes
management is important in preventing the same barriers. Understanding why patients are
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not able to self-manage their diabetes is important for the patient, the family, and the
health care provider. Decreasing cost and complications and improving quality of life
and patient satisfaction for both males and females is important to stockholders that
finance health care for the uninsured, insurance payers, and the country, including
patients and families. Disease awareness and adherences to medications with diabetes
Type II among Latinos will decrease complications such as retinopathy, peripheral
neuropathy, kidney disease, coronary artery disease, and depression. Adherence to
medications prevents premature deaths, preserves body image, improves well being, and
increases family, patient social satisfaction. Adherence to medications improves the
patients psychological well being and it empowers the patient to self-mange his/her
diabetes type II a chronic disease.
The findings of this study could assist in changing or improving national policies
in relation to self-management of Latinos with diabetes Type II. Health education,
reading materials, or videos should be provided in areas such as waiting rooms.
Incentives such as t-shirts or coupons may be offered to patients as a way to bring them
into health education classes. Physicians should be persuaded to offer summarized
recommendations or to push for patients to take more health education classes. Funds
may be considered through grants in order to promote diabetes Type II health education
awareness through the media on a regular basis or in the weekly newspaper.
Conclusion
I found that only 46.5% of Latino patients receiving treatment in the community
clinic in Fresno County California adhered to medications (chi-square = 7.734; p = .005).
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It is important to reach out to physicians, nurses, health educators, nutritionists, and other
health care providers across the country with significant predictors of diabetes Type II
medication nonadherence to prevent complications and to start early intervention because
they are gateways to their communities. Physicians play a key role in promoting diabetes
Type II awareness and health education referrals because patients have closer
relationships with their physicians. Thus, patients are more likely to adhere to
recommendations given by their physicians rather than from other sources. Family
members of patients with diabetes Type II also need to be made aware of the implications
of diabetes Type II so that they may reach out and suggest lifestyle modifications, diet,
and exercise. Patient awareness can be increased through accountability to others while at
the same time learning to self-manage diabetes Type II.
Migrant worker status requires goal settings for both the health care provider and
the patient to self-manage his or her diabetes Type II when on the road. Patients need to
be educated about the self- management of his or her medication by mouth and how to
inject insulin. Learning how to prevent hypoglycemia reactions when working on the
field or when on the road is an important step in patients taking responsibility for their
diabetes Type II management. Blood glucose testing is important and knowing how to
interpret and respond to the blood glucose findings. It is important to get the family
involved in the self-care of the patient, including diet and exercise
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